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Thesis Abstract 
 Low grade brain tumours make up approximately 45% of all brain tumour diagnoses 
each year in the UK, of which 10% are pituitary tumours. People with low grade and pituitary 
tumours can experience a wide range of physical, psychological and cognitive difficulties. 
Studies have reported mixed results in regard to the extent and cause of psychological and 
cognitive difficulties. However, qualitative research has highlighted the need for a greater 
understanding of the experience of low grade and pituitary tumours, in order to provide best 
care and support.  
 In section one, studies with information regarding the psychological and emotional 
wellbeing of people with primary low grade brain tumours were systematically reviewed. A 
total of 14 papers were identified, and a meta-synthesis approach was utilised. The results 
highlighted significant psychological and emotional turmoil for people with a primary low 
grade brain tumour. Results demonstrated that the low grade morphology of a brain tumour 
does not diminish the overall distress in comparison with high grade tumours, though the 
focus on mortality was less constant. Findings demonstrated the need for significant 
psychological support for people with a low grade brain tumour, and further potential 
research was discussed.  
 Section two explored the experiences of people with a history of pituitary tumour in 
regard to cognitive difficulties and neuropsychological testing. Individual interviews were 
conducted, and analysed using Interpretative Phenomenological Analysis. Results revealed 
cognitive functioning as an underlying source of distress during pituitary tumour care and 
showed how neuropsychological testing can be beneficial. Clinical implications and potential 
future research were discussed.  
 Section three was used to reflect on a variety of issues which arose during the 
research process, and to reflect on the results and implications of the research study.  
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Abstract 
The purpose of this qualitative meta-synthesis was to explore the psychological and 
emotional experience of having a primary low grade or benign brain tumour. 
Electronic databases were systematically searched according to specified inclusion 
and exclusion criteria. A total of 14 qualitative papers were included for final review, 
using an adapted meta-synthesis approach based on guidance from Noblit and Hare 
(1988). Relevant themes and interpretations were extracted from the selected papers, 
and used to generate six final themes which represented the entire data set. These 
were: emotional states; interaction with health care professionals; change and coming 
to terms; re-evaluating; the importance of reassurance, support, and hope; and looking 
back vs. looking forward. The findings highlight the significant psychological and 
emotional turmoil experienced by people with a primary low grade brain tumour, and 
identify potential areas for professional involvement. Findings, strengths, limitations, 
clinical implications and areas for future research are discussed.  
         Keywords: brain tumour, meta-synthesis, review, low grade, benign, qualitative 
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An Examination of the Psychological and Emotional Experience of Having a 
Primary Low Grade Brain Tumour – A Meta-Synthesis of Qualitative Research 
 
Introduction 
In the United Kingdom brain tumours make up approximately 3% of cancer 
diagnoses, with a prevalence rate of 15 out of every 100,000 in the general 
population, split evenly across men and women (Cancer Research UK, 2011). 
Primary brain tumours are those tumours which begin within the brain, and are not the 
result of metastases from other forms of bodily tumour. Low grade tumours are those 
tumours which do not present as malignant, meaning they are unlikely to grow rapidly 
or spread to other areas. There is however a risk of malignant transformation in this 
type of tumour, meaning the tumour can begin as low grade but become high grade.  
Primary low grade brain tumours (PLGBT) make up approximately 45% of all brain 
tumours diagnosed each year (Cancer Research UK, 2011).  
Within brain tumour research, psychological status and wellbeing is 
commonly assessed as part of a wider concept of quality of life (QoL). At present no 
single gold standard QoL assessment exists to assess people with a brain tumour 
(Pace, Villani , Zucchella & Maschio, 2012) and psychological difficulties form only 
one part of QoL studies (e.g. Johnson, Woodburn & Vance, 2003; Van der Klaauw et 
al., 2008; Page, Hammersley, Burke & Wass, 1997; Tooze, Gittoes, Jones & 
Toogood, 2009). The experience of having a brain tumour brings duality in “the 
trauma and uncertain prognosis associated with cancer diagnosis [and] the direct 
neurological effects of the tumour” (Ownsworth, Hawkes, Steginga, Walker & Shum, 
2009, p. 1038). Brain tumour patients experience a direct threat to their life, but also 
to their personality (Adelbratt & Strang, 2000). Quantitative studies have 
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demonstrated a number of fundamental issues when considering the psychological 
wellbeing of adults with a primary brain tumour (both malignant and low grade). 
Issues such as anxiety and depression have a negative impact on QoL (Flowers, 2000; 
Heimans & Taphoorn, 2002; Khan & Amatya; 2013; Ownsworth, Hawkes, Steginga, 
Walker  & Shum, 2009; Tooze, Gittoest, Jones & Toogood, 2009; Tsay, Chang, 
Yates, Lin & Liang, 2012;Vargo, 2011) and self-report measures have found anxiety 
and depression have a substantial impact on confidence, independent living ability 
and participation in social and family activities (Khan & Amatya, 2013) which can 
further impact psychological wellbeing.  
A number of systematic reviews have been conducted to investigate areas of 
brain tumour experience. Huang, Wartella, Kreutzer, Broaddus & Lyckholm (2001) 
reviewed quantitative literature regarding functional outcomes and quality of life in 
patients with a brain tumour, and found significant changes in quality of life over the 
course of brain tumour experience. Sterckx et al. (2013) analysed sixteen qualitative 
papers relating to the impact of high grade glioma on everyday life for people with a 
brain tumour and their carers. They reported on areas such as supportive care and 
information needs, the financial implications, the change in roles and the process of 
diagnosis. Underpinning a number of their findings were emotional concepts such as 
shock, anxiety, depression and anger. Moore et al. (2013) reported on the palliative 
and supportive care needs of high grade glioma patients and their carers. They 
combined psychological needs with social, and found issues such as maintaining 
hope, the importance of relationships and struggling with cognitive impairments to be 
paramount. These reviews demonstrate several issues, firstly that the psychological 
and emotional consequences of PLGBT are pivotal in the broad experience of having 
a brain tumour, that despite this they are often regarded as secondary to more social or 
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practical issues, particularly in larger reviews, and lastly that focus has tended to be 
on high grade, malignant tumour types. This focus may be because there is an 
assumption that the experience of people with high grade tumours will be worse than 
those with low grade, due to the increased chance of death. Additionally these reviews 
tend to focus on one tumour type, reducing generalisability to other tumour types.  
As demonstrated, when included as part of larger whole (along with social and 
physical issues) the exploration of psychological wellbeing can become 
overshadowed. More detail on the psychological difficulties facing people with a 
brain tumour can be found in the idiographic qualitative studies of brain tumour 
experience. Some studies do attempt to focus on a singular psychological issue facing 
people with a brain tumour, for example studies of anxiety (e.g. Jagadeesh & 
Bernstein, 2014), however psychological difficulties are also often part of a wider 
exploration of experience, such as the experience of symptoms (e.g. Molassiotis et al., 
2010). As yet no review has drawn together the psychological and emotional elements 
of these qualitative studies to assess the commonalities in the psychological 
experience of having a PLGBT. 
The practice of meta-synthesis in qualitative research aims to draw together 
larger numbers of qualitative studies, and evaluating their commonalities to produce a 
larger data pool, which can be viewed as more robust than any one study alone. 
However, qualitative data must be considered using criteria other than 
generalisability, with focus on individual experience, with the possibility, but not 
certainty, that issues arising may affect the wider population. Meta-synthesis involves 
the re-interpretation of qualitative data to produce a novel set of findings (Pope, Mays 
& Popay, 2007) with the hope that these combined findings provide a more in depth 
and better understanding of the sensitive issues often addressed by qualitative 
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research (Boland, Cherry & Dickson, 2014). As argued, emotional wellbeing in 
people with a brain tumour constitutes both an area with a number of isolated 
qualitative studies and an area which receives limited research focus compared to 
other issues. This makes it a good candidate for the use of a meta-synthesis approach. 
Whilst every person with a low grade brain tumour may have a different experience, 
and experiences may differ across tumour type, understanding any commonalities in 
experience can help clinicians to be more prepared and subsequently make more 
informed choices regarding care. Consequently, the current review will utilise a 
qualitative meta-synthesis approach (Noblit and Hare, 1988) to draw together 
qualitative evidence regarding the psychological and emotional experience of having 
a PLGBT, within the scope of the inclusion and exclusion criteria established below. 
This review aims to highlight those difficulties and concerns common across people 
with a PLGBT, and to identify areas for potential support.  
Method 
Search strategy  
Identification of papers for this review was conducted through a computerised 
search of four academic databases, these included: PubMed (incorporating MEDLINE 
and additional life science sources), PSYCINFO, CINAHL and Academic Search 
Complete. The search was limited to peer-reviewed journals published in English, and 
was conducted between November to December 2014. When using the PubMed 
database, an additional filter of human research was used to exclude any studies done 
with animals.  Search term thesauri were consulted using an initial search term set, to 
ensure full and appropriate search terms were used, this resulted in additional terms 
such as neoplasm (more commonly used in the USA). Brain tumour search terms 
were based on the inclusion of all known tumour types.  There are over 130 
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morphologies of brain tumour (Louis, Ohgaki, Weistler, Cavenee, 2007), which 
necessitated an extensive list of search terms. Some specific types of brain tumour 
have names which are partially shared with others, for example multiple forms of 
Glioma, this meant search terms could be reduced to include only the necessary words 
which would identify multiple tumour types. The full list of search terms can be found 
in Appendix 1-B.  
The search terms used were deliberately broad, and it was recognised this 
would result in a number of papers which were unsuitable for review here, such as 
those focussing on malignant tumour types. However in the interests of ensuring all 
relevant papers were included, broad search terms were necessary. All search terms 
were applied to each database consulted. The searches were done as a free text search, 
once the exploration of search terms had been completed using thesauri, as outlined 
above. Databases such as PubMed and Academic Search Complete also have an 
automatic mapping search tool, which allows the users search terms to be 
automatically expanded out to include available associated terms, this option was 
utilised to ensure maximum article inclusion.  
All abstracts were then examined, and those that potentially met the inclusion 
criteria were examined in greater detail. A manual search of the reference lists of 
papers identified was also conducted, to identify other articles that may have met the 
inclusion criteria. Table 1 outlines the specific inclusion and exclusion criteria used to 
determine whether a paper was to be included in this review, along with a rationale 
for each criterion.  
------------------------------------------------------------------------------- 
Insert Table 1 here 
------------------------------------------------------------------------------- 
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Search results 
The search yielded 1957 results which were all examined by title and abstract. 
Twelve papers met the criteria for final inclusion, and an additional 2 were added 
from a manual search of reference lists within papers. Therefore a total of 14 papers 
were included for review. The numbers of papers found, examined and included or 
excluded at each stage can be found in the flow diagram in Appendix 1-A, along with 
further detail of how inclusion and exclusion criteria were applied at each stage.  
The majority of papers excluded were removed on the basis of  the inclusion 
criteria alone, primarily being quantitative, not being focussed on PLGBT or having 
any aspect of psychological wellbeing. A small number of papers were excluded 
based on the exclusion criteria, for example being too specific and only tangentially 
related to the subject. For example, one paper was excluded as it focussed solely on 
the impact of religious beliefs on brain tumour experience. Whilst this contained 
elements of psychological thinking, it would not have aided in answering wider 
questions about common psychological experience.  
Characteristics of the included studies 
A summary of the main characteristics of each study are presented in Table 2. 
Individual research questions varied between papers, however all included studies 
aimed in some way to explore qualitatively some aspect of the experience of having a 
primary brain tumour. The majority of studies (11/14) used individual semi-structured 
interviews, three used a combination of individual interviews and focus groups and 
one study used recordings of existing group therapy sessions.  
Only one paper exclusively examined on psychological experience (Jagadeesh 
& Bernstein, 2014), whilst the rest focussed on broader issues but included themes 
which incorporated psychological experience (Cavers, et al., 2012; Cavers, et al., 
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2013; Cornwell, Dicks, Fleming, Haines & Olson, 2012; Edvardsson & Ahlstrom, 
2005; Edvardsson, Pahlson & Ahlstrom, 2006; Fox & Lantz, 1998; Gurel, Bruening, 
Rhodes & Lomax, 2014; Hayhurst, Mendelsohn & Bernstein, 2010; Janda, Eakin, 
Bailey, Walker & Troy, 2005; Leavitt, Lamb & Voss, 1996; Molassiotis et al., 2010; 
Ownsworth, Chambers, Hawkes, Walker & Shum, 2010; Simpson, Heath & Wall, 
2014). 
Thirteen studies used mixed male and female samples, with one study not 
reporting their sex statistics (Fox & Lantz, 1998) and participant ages ranged from 18-
82 years. Some studies included information from families and carers as well as 
people with a brain tumour, wherever possible data exclusively from people with 
tumours themselves were extracted. Studies were conducted in the UK, Australia, 
Sweden, USA and Canada, and ethnicity was only sporadically reported.   
Studies utilised a variety of qualitative methodologies, four utilised grounded 
theory, four used content analysis, three used thematic analysis, one used narrative 
and two referred to general qualitative phenomenological principles. Choice of 
methodology was also used to help make a determination about the epistemological 
stance of each paper (Bannister, Bunn, Burman & Daniels, 2011, p. 10; Willig, 2013, 
p. 52) as this was not directly cited in any paper. As this is the first meta-synthesis in 
this subject area, a range of methods and epistemological stances were included, 
however they all shared an inductive approach to their qualitative research.  
------------------------------------------------------------------------------- 
Insert Table 2 here 
------------------------------------------------------------------------------- 
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Quality assessment  
All of the selected studies were subjected to a quality appraisal using the Critical 
Appraisal Skills Programme tool (CASP, 2013). This tool aids in the systematic 
appraisal of quality in qualitative papers, covering 10 areas such as appropriate design 
and methodology, ethical considerations and appropriate analysis. The quality 
appraisal was undertaken by the main researcher alone, as was the decision whether to 
exclude any papers. Exclusion decisions were made based on whether a study 
appeared to have a higher number of reporting flaws than the collective, and whether 
the removal of a study would be of detriment to the final synthesis.  
 Walsh & Downe (2006, p109) note that without quality appraisal a meta-
synthesis can be flawed. Walsh & Downe recognise the idea of appraising qualitative 
research for specific quality is contestable based on the variety of epistemological 
stances adopted by qualitative research, which may reject the traditional idea of 
quality in research, which is based in reliability and validity. However, they cite 
Murphy et al. (1998) in saying that practical concerns such as whether research 
should be funded, mean at least an attempt to approximate some kind of wider truth is 
necessary.  
No study was excluded as a result of the appraisal conducted, as quality was 
determined to be generally good across all included papers. There were a small 
number of consistent reporting quality gaps across papers, for example papers failing 
to justify their research design or discuss the relationship between researcher and 
participant. Table 3 presents a summary of the findings from the quality appraisal 
process. 
------------------------------------------------------------------------------- 
Insert Table 3 here 
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------------------------------------------------------------------------------- 
Meta-synthesis process 
The meta-synthesis process used the style established by Noblit and Hare (1988, p. 
26-29) to proceed through the following steps: (1) Identifying the subject area; (2) 
searching and selection of relevant studies; (3) reading the studies; (4) determining 
how the studies are related; (5) translating the studies into one another; (6) 
synthesising the translations; (7) expressing the synthesis. This approach relies on the 
synthesis of the interpretations made in studies, rather than the synthesis of raw data 
(Doyle, 2003). The approach by Noblit and Hare is categorised as a meta-
ethnographic approach, and as such they suggest the use of only 3-5 papers (Noblit & 
Hare, 1988). This review looked to adapt this approach by utilising an increased 
number of papers, whilst maintaining the approach of synthesising interpretative data. 
Table 4 gives an overview of the main psychological wellbeing findings 
extracted from each of the included studies. Table 5 demonstrates the synthesis of 
individual study themes into final meta-themes. The interpretative data extracted from 
the studies was limited to information surrounding psychological experience. This 
meant that for a number of papers, only a selection of themes from their overall 
collection were utilised in the synthesis. Where possible only data regarding the low 
grade participants in mixed population studies was extracted. Where this data was 
fully integrated, an assumption was made that the themes represented issues which 
were prevalent in both populations and therefore relevant to this meta-synthesis. 
------------------------------------------------------------------------------- 
Insert Table 4 here 
-------------------------------------------------------------------------------#
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------------------------------------------------------------------------------- 
Insert Table 5 here 
------------------------------------------------------------------------------- 
Reflexive Statement1 
 I attempted to remain reflexive whilst conducting this literature review, in part 
this meant ensuring I was aware of my own thoughts, feelings and perspectives and 
how these could influence my data analysis. My experience of working with people 
with a low grade brain tumour was that they do not always receive similar levels of 
support as people with high grade tumours. I recognised a motivation to help improve 
services in this areas and subsequently I needed to be cautious of over-interpreting 
results to this end.  
 As with my research paper I adopted a realist social constructionist (Elder-Vass, 
2012) epistemology which integrated both my view that the individual participants were 
communicating their own constructed meaning and that their experiences would be 
influenced by wider social structures which required acknowledgement.   
Results 
The meta-synthesis process resulted in six themes relating to both the direct 
psychological impact of having a PLGBT and those factors which influence it. These 
themes were: emotional states; interaction with health care professionals; change and 
coming to terms; re-evaluating; the importance of reassurance, support and hope; and 
looking back vs. looking forward. Noblit & Hare (1998) suggest using the titles from 
the study themes to form the titles for the meta-synthesis themes. This was done 
where possible, and where the original themes did not reflect the newly constructed 
meta-synthesis theme, a new theme title was created. Four of the six final themes used 
titles from the original studies (emotional states; interaction with health care 
######################################## ####################
1#This#section#is#written#in#the#first#person#to#ensure#clarity##
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professionals; re-evaluating; and the importance of reassurance, support, and hope). 
Figure 1 gives a diagrammatic overview of the meta-synthesis themes and how they 
relate to one another.  
------------------------------------------------------------------------------- 
Insert Figure 1 here 
------------------------------------------------------------------------------- 
Emotional states  
Ten of the fourteen studies contributed to this theme, which was the largest in 
both numbers of studies contributing and total number of constituent themes. This 
highlights the importance of the impact that having a PLGBT has on emotional state. 
The theme encapsulates the direct discussion of emotional wellbeing as an issue in 
itself, rather than as a consequence of other factors (as discussed in later themes). The 
theme overall demonstrated the significant influence emotional state can have on the 
thoughts, feelings and behaviour of people with a PLGBT. The emotional state of 
participants across studies affected the choices they made in relation to their care, 
relationships and attempts to move forward in their lives. Studies discussed a plethora 
of emotions, most commonly difficulties with anxiety, anger and depression (Cavers 
et al., 2013; Edvardsson & Ahlstrom, 2005; Gurel, Bruening, Rhodes & Lomax, 
2014; Hayhurst, Mendleson & Bernstein, 2010; Leavitt, Lamb & Voss, 1996; 
Molassiotis et al., 2010; Ownsworth, Chambers, Hawkes, Walker & Shum, 2010 and 
Simpson, Heath & Wall, 2014), but also with compound psychological constructs 
such as devastation (Hayhurst et al., 2010), control (Gurel et al., 2014; Molassiotis et 
al., 2010; Simpson et al., 2014) and shame (Edvardsson & Ahlstrom, 2005; 
Edvardsson et al., 2006).  
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Emotional distress and volatility permeated every stage of the psychological 
journey through experiencing a PLGBT. Study participants described how 
overwhelming the sense of emotion could be (Hayhurst et al., 2010) but also how 
difficult it can be to express emotion (Edvardsson & Ahlstrom, 2005), sometimes 
leading to further feelings of isolation and helplessness, even from professionals: “the 
doctor stops talking if I cry” (Leavitt et al., 1996, p. 1250). Fox & Lantz (1998) 
described how the stigma of mind-body illness can result in people hiding their 
feelings: “You feel so alone. You want to talk about it, but no one can see that you 
have it” (Fox & Lantz, 1998, p. 247) 
The emotional impact of the tumour diagnosis was unexpected for some: “to 
tell you the truth, I think, once you’ve had it removed, you maybe think the worst is 
over” (Simpson et al., 2014, p. 168) and some described a sense of bewilderment at 
the complexity of their situation (Gurel et al., 2014). Participants described a feeling 
of being out of control: “I can’t do anything about it” (Molassiotis et al., 2010, p. 413) 
and this leading to a sense of desperation as they searched for answers and 
understanding (Simpson et al., 2014), sometimes concluding in feelings of relief or 
acceptance, despite bad news (Gurel et al., 2014; Hayhurst et al., 2010) 
The emotional difficulties described in this theme were both the result of and 
the cause of a number of the difficulties and experiences described in later themes. It 
became evident throughout this meta-synthesis that emotion underpinned all aspects 
of psychological wellbeing. Figure 1 demonstrates how the emotional state of the 
participants influenced and was influenced by all other themes.  
Interaction with health care professionals 
This theme emerged from a commonality in the ways the studies discussed the 
way relationships and interactions with health care professionals (HCP) can impact on 
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emotional wellbeing during the various stages of having a PLGBT. The idea of 
having knowledgeable and accessible professionals was prominent in this theme, and 
often mediated the fluctuations in a person’s mood: “My most important resource is 
my endocrinologist...He has helped me through some very difficult times” (Gurel et 
al., 2014, p. 59).  Relationships with HCPs were seen as the foundation of trust and 
confidence in medical care (Gurel et al., 2014), able to reduce anxiety (Hayhurst et 
al., 2010) and able to influence the emotional impact of brain tumour discovery and 
diagnosis: “It didn’t seem like a big deal; there was no concern or crisis expressed by 
the doctors. So I did everything in a relaxed way, I was pretty happy about it.” 
(Jagadeesh & Bernstein, 2013, p. 378). Trust was not only needed in the HCP’s 
abilities, but also required from the HCP towards the patient (Edvardsson, Pahlson & 
Ahlstrom, 2006).  
Alongside the discussion of the importance of this relationship with HCPs was 
the discussion of how difficult it can be to establish these positive relationships and 
the negative impact that this can have on the emotional and psychological state: “Five 
years it took begging people to look at me...this condition can drive someone mad, but 
it does not help with some of the medical professional’s attitude” (Gurel et al., p. 56). 
Frustration in dealing with ‘medical diplomats’ who do not listen was evident (Fox & 
Lantz, 1998) and studies discussed how people can be left feeling abandoned 
(Edvardsson et al., 2006) and even “orphaned” (Gurel et al., 2014, p. 58) when they 
are unable to establish a good relationship with their HCP: “What makes me almost 
the angriest is that they did not take more notice. When a patient comes back time and 
time again complaining of the same thing, you don’t just tell  them to take an aspirin 
and go home” (Edvardsson et al., 2006, p. 419). Additionally the level of information 
given, or not given, by professionals played an important role in the levels of anxiety, 
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uncertainty and “negative forecasting”: “When you’re left to your own devices it’s 
only human nature to come up with the wrong conclusions” (Cavers et al., 2013, 
p.1302).  
 Overall, this theme highlights the importance of a positive relationship 
between brain tumour patient and HCP, and demonstrates how this relationship can 
have a positive or negative impact on psychological wellbeing. Figure 1 highlights 
how this theme in particular fed into the importance of reassurance, support and hope, 
and how these themes together then influenced the wider emotional state and patterns 
of thinking.  
The importance of reassurance, support, and hope 
Six papers contributed to this theme, which encapsulated the needs of people with 
PLGBT to feel supported and possessed of hope for the future. Support and hope were 
drawn from a variety of sources, but most prominently from HCPs and family 
members.  
In addition to those functions detailed in the above theme, HCPs performed an 
important role in providing reassurance, support and, crucially, hope, to people with 
PLGBT. People with a low grade tumour can be less likely to have the same 
immediate concerns about death as people with high grade tumours, making them 
more likely to hold on to increased hopes for a recovery: “So I just hope it doesn’t 
start growing again” (Cavers et al., 2013, p. 1302). When HCPs do not focus on 
providing reassurance and emotional support, hope and positive adjustment were 
more difficult to achieve (Cavers et al., 2013) and this can increase the emotional 
turmoil experienced: “It felt like a roller coaster. There’s a fear factor, a large quantity 
of unknown; it’s like being in the middle of a mental desert and there’s a sandstorm 
and you don’t know what to do” (Jagadeesh & Bernstein, 2014).  
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When people are unable to find the support they needed in HCPs they may 
attempt to seek support independently, with this gap often being filled by family 
members: “...I got in touch with the community health people to see if they did have 
somebody that could come a couple of times a week...but they don’t do short term so 
unless I’d looked up in the paper and got somebody private...but my family said no, 
they’d handle it so that’s what they’ve done” (Cornwell et al., 2012, p. 2601). Family 
support covered a broad range of input, including support with managing uncertainty 
and anxiety, attempts to return to pre-diagnosis roles and responsibilities and 
overcoming stigma and discrimination (Janda, Eakin, Bailey, Walker & Troy (2005). 
However, family input also led people with a tumour to worry about the burden on 
their family member carers (Janda et al., 2005, Ownsworth, Chambers, Hawkes, 
Walker & Shum, 2010) and to consider their new positions in the family: “I had the 
classic, ‘You can go back to work in a couple of months, everything will be fine’. No, 
the wife’s the main breadwinner and she’s got this disabled husband on her hands” 
(Ownsworth et al., 2010, p.128). In these scenarios it was all the more important that 
people with tumour felt supported and were able to reach out to family, HCPs and 
other sources, in order to maintain hope: “I managed to speak to a young lady who 
had just had a debulking done and she was my inspiration that everything’s going to 
be fine” (Ownsworth et al., 2010, p. 129)  
Wherever hope comes from it was a vital thread throughout this theme, and 
one which acted as a positive coping strategy for people with PLGBT, providing drive 
and motivation to live on: “Whatever happens, I’m going to live to the age of 80. I’ve 
made up my mind” (Edvardsson & Ahlstrom, 2005, p. 733) 
 Reassurance, support and hope were first sought from the interactions with 
healthcare professionals and then from wider sources such as family, as demonstrated 
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in Figure 1. The satisfaction with the levels of reassurance, support and hope received 
then went on to influence the emotional state and the ways of thinking about 
participants’ circumstances. Likewise the emotional state and current ways of 
thinking (e.g. current grief over past life or stage of coming to terms) influenced how 
people viewed their interactions, support and subsequent hope. 
Change and coming to terms  
 Change, and adjustment to change, was discussed in seven of the papers. 
Change was evident in multiple areas of a person’s life including practical, social, 
relational and occupational, all of which resulted in frequent change in psychological 
and emotional wellbeing (Edvaardsson, Pahlson & Ahlstrom, 2006).  
Changes to roles within family life and the emotional difficulties this brings 
were particularly emotive in discussions. People with a tumour found themselves 
increasingly unable to care for themselves or others (Leavitt, lamb & Voss (1996) and 
often were left with feelings of being a burden to others. These feelings were dealt 
with by either finding ways to increase independent activities, such as part time work 
(Molassiotis et al., 2010) or by masking emotional and physical difficulties: “Learn to 
be guarded over your emotions and your tiredness and everything like that (.) erm (.) 
so you feel loathed to actually speak out about how you are feeling” (Simpson et al., 
2014, p.170) 
 In addition to influence from external change factors, psychological change 
was also stimulated by internal thought processes such as shifts in priorities and 
perspectives (Cornwell, Dicks, Fleming, Haines & Olson, 2012). The studies 
demonstrated an increasingly fluid and turbulent nature within the ongoing 
psychological wellbeing of people with a PLGBT. In reality, these internal and 
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external change processes are likely to be interrelated and to have significant effect on 
one another.  
Lastly, participants in the studies described the process of coming to terms 
with all of the changes present in their lives. For some this was a difficult process, and 
involved emotional distress and feeling of isolation, while others struggled to find 
purpose in their lives: “...I don’t feel like I’ve got any purpose. I don’t know where 
I’m going. I want to work but...Yeah I sort of feel quite lost really and am drifting 
every day.” (Cornwell et al., 2012, p. 2605). Some participants described finally 
coming to terms as both acceptance and using change to help coping. For example, by 
finding new ways to think about work or recreational activities: “So maybe I won’t be 
100% OK in my left side, but it doesn’t matter. Life goes on. Things are the way they 
are, there’s no point getting hung up about it” (Edvaardsson & Ahlstrom, 2005, p. 
733) 
Looking back vs. looking forward 
This theme utilised themes from six papers, and comprised two distinct but 
connected elements of the psychological processes involved in adjusting to life during 
and after PLGBT. The idea of looking back to life before the tumour symptoms and 
diagnosis and comparing that to life now are common themes in the data. This is 
partnered by those times when a person looks forward towards the future, including 
positive attempts to make life progress and more anxious worry about things to come.  
 Fox & Lantz (1998) referred to the “invasive disease of the self” (p.247), 
which demonstrates the extent to which people with a tumour can negatively evaluate 
the changes to their sense of self. Reflection and comparison to the past can create a 
sense of having lost the past self: “I think I remember who I used to be, but the further 
it gets away the harder it gets...” (Fox & Lantz, 1998, p. 247). This reflection on the 
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past can be triggered by the slow realisation over time that difficulties are permanent 
(Leavitt et al., 1996).  
In the early stages of tumour experience, participants discuss a “fighting 
spirit” (Molassiotis et al., 2010, p. 414) when looking forward, but over time this is 
lost, and replaced by a loss of hope regarding continuing progress and grief over what 
has been lost .  
When people look back on their experiences there can be a process of 
hypothesising over what could have been if circumstances had been different, 
sometimes leading to attributions of blame: “He refused to order any blood tests. Now 
if he had ordered them then, it would have been a very small tumour at that 
stage...there is a lot of anger at that” (Ownsworth et al., 2010, p. 130)   
 Whilst some focus on the past in this way, others look forward to the future 
with both anxiety and positivity, depending on the person and the circumstances. It 
may also be that this is a staged process where looking back is a step towards being 
able to look forward. Some people express a fear of the future (Simpson et al., 2014) 
and an uncertainty about what will come next for them, leading them to question what 
the whole process will mean for them (Ownsworth et al., 2010).  
For some, looking to the future continues to hold a hope for full recovery: “I 
would just like to feel me again, and not have these stupid emotions...I just want to 
feel normal again, back to the normal me.” (Simpson et al., 2014, p. 172). For others 
this is more of a recognition that they will need to learn to cope with their difficulties 
(Leavitt et al., 1998). This recognition of the need to adjust leads some to make 
practical adjustments in order to support their own psychological wellbeing. For 
example, by recognising that some tasks and responsibilities are now beyond them, a 
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person can begin to establish new goals which are achievable and give a sense of 
positive attainment (Edvardsson & Ahlstrom, 2005).   
Lastly, within this theme there was an examination of how people perceived 
their quality of life in comparison to the past, and how it would be going forward. 
Two main points came from this, firstly that for some this was felt as a loss of past 
quality of life, but a recognition of the importance in “living life to the fullest” (Fox & 
Lantz, 1998, p. 248) going forward. Others felt that their quality of life had not been 
impaired to any significant degree by their tumour, but this then became a focus of 
anxiety for them. For example the fear that intervention (such as surgery) would cause 
neurological deficits where previously none existed: “If it affects my quality of life 
then it [surgery] is not worth it...if something does come we’ll deal with it then” 
(Hayhurst et al., 2011, p. 259) 
Re-evaluating 
This theme was formed from those times when study participants were able to 
experience the situations, difficulties and psychological changes described in the 
themes above and come to re-evaluate their situation with some positive reflection 
points. This usually represented a late stage of thought processes from participants in 
studies, and the ability to find positives was not easy or even achievable for some.  
 Edvardsson & Ahlstrom (2005) described this type of positive reflection as a 
process of re-evaluation which acts as a coping mechanism for people with a tumour, 
for example participants reported feeling positive about losing weight, or even 
focussed on ways they were special and unique, such as their tumour being unusual 
(Edvardsson et al., 2006).  Additionally study participants sometimes felt fortunate for 
having accessed healthcare, or having their condition discovered: “Once they got 
these images, it scarcely took more than a week. Then I got word that I had to get 
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moving. It happened very quickly then, and that was good!” (Edvardsson et al., 2006, 
p. 419).  
Lastly, there was a tendency to come to place more value on the ordinary 
aspects of their lives, and on life itself: “So it’s a changing person if you like, so every 
time I go out for a walk I think oh I’m here, you know, even the simplest things in life 
you think this is great” (Molassiotis et al., 2010, p.413). A sense of gratitude for still 
being alive (Edvardsson & Ahlstrom, 2005) was an important factor in helping people 
to improve their psychological wellbeing, and conversely an increased level of 
psychological wellbeing overall was linked to a more positive outlook on life 
(Molassiotis et al., 2010).  
The three themes of: looking back vs. looking forward, change and coming to 
terms and re-evaluating form a triad of thinking processes which occur for people 
with a PLGBT, each influencing the others. Collectively these processes then go on to 
influence the emotional state of the person and perceptions of situations such as HCP 
interactions and support. Conversely, these thinking process are also influenced by 
these other factors. This interaction is demonstrated in Figure 1.  
Discussion 
This meta-synthesis drew together qualitative findings regarding the 
psychological experience of people with a primary low grade brain tumour. Whilst the 
majority of the papers used had a broader scope than this, such as overall quality of 
life, the meta-synthesis process allowed for the extraction of only that data which was 
relevant to psychological and emotional experiences. The review aimed to elucidate 
information regarding the psychological experience of having a PLGBT and to 
highlight areas for potential support, and it has achieved this.  
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 The results regarding the emotions involved in the experience of PLGBT share 
a number of similar results found in qualitative and quantitative research into high 
grade brain tumour (Huang et al., 2001; Moore et al., 2013; Sterckx et al., 2013), 
suggesting that any assumption of low grade tumour experience being less 
emotionally and psychologically taxing than high grade may be flawed. Experiences 
are characterised by strong emotions of anxiety, depression, shock and difficulties 
adjusting. The synthesis demonstrated a particularly strong tendency for fluctuation in 
emotion for people with PLGBT, particularly between fears and anxieties for the 
future and attempts to reclaim a normal life. This variable pattern is perhaps more 
prominently seen here than in high grade research, perhaps due to difference between 
potential for death because of the tumour, as opposed to a certainty in most high grade 
cases.  
 The suggestion that having a tumour can be an “invasive disease of the self” 
(Fox & Lantz, 1998, p. 247) may suggest that for some, the person they are when they 
receive a diagnosis may be very different to the person they are later in the 
experience. Identity theory is a useful vehicle for considering these issues, for 
example the humanist approach to self-concept, which includes self image, self 
esteem and the ideal self (Rogers, 1959). In this model, all three aspects of the self are 
potentially affected when the core self, in psychological and neurological domains, is 
changed via PLGBT experience. This area of identity has also been more extensively 
considered in traumatic brain injury research (Carroll & Coetzer, 2011) and other 
neurological conditions, and this may be useful in helping to draw comparisons with 
identity change in future research and in considering service model changes. When 
drawn together, the information regarding identity change presented here suggests a 
cycle of change which may result in significant changes across psychological, 
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personality, lifestyle and behaviour domains. Full exploration of this cycle or model 
for change is beyond the scope of this review; however further exploration may be 
beneficial in a future project.  
 Identity change and psychological and emotional changes associated with 
PLGBT are part of the recovery process commonly seen in neuropsychological 
practice. Neuropsychological recovery theory allows clinicians to help people begin 
to process their experiences and move towards some form of recovery. For example 
the Y-shaped process model of rehabilitation (Wilson, Gracey, Evans & Bateman, 
2009) aims to help people with neuropsychological presentation reduce the 
discrepancy between the past self and the current self, thus helping the person to adapt 
to the reality of their current situation. The synthesis here provides strong indication 
that this form of identity linked rehabilitation model and subsequent intervention are 
key in the continuing psychological wellbeing of people with PLGBT.  
The capacity  PLGBT patients to experience significant change over time in 
provides both a point of caution and of hope. By helping people to manage the 
negative changes carefully, and by promoting positive change and adjustment, we can 
help to prevent declines in psychological wellbeing and promote positive focus on the 
future.   
Strengths and limitations 
This synthesis is the first to draw together available qualitative research 
regarding people with a primary low grade brain tumour. As such it has a particular 
strength in being novel and potentially useful for clinical practice (as discussed later). 
The exploratory nature of this kind of synthesis provides a valuable contribution to 
the understanding of brain tumour experience. National guidelines clearly outline the 
psychological needs of people being treated for a primary brain tumour, but place 
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much of the emphasis for psychological care on support services and 
neuropsychological services (National Institute for Health and Care Excellence, 
2006). This synthesis provides psychological knowledge and understanding which 
can be applied to help broaden the medical understanding of low grade brain tumours 
as a health condition. In this way a more holistic understanding of people with a brain 
tumour can be gained by all professionals, and used to work positively with people’s 
psychological difficulties.  
The specific methodological flaws discussed in the quality appraisal section of 
this review, whilst not enough to justify the removal of any papers, may have 
influenced the overall quality of this review. For example, Yardley (2000) explains 
that consideration of the relationship between researcher and participant is an 
important part of methodological quality and research ethics. Since this was present in 
only four of the papers used, assessing the overall quality was made more difficult 
and thus the final results cannot reflect these issues. However, it is important to 
recognise that the methodological quality reported for these papers is only a reflection 
of reporting quality, not necessarily actual flaws in the methods or ethics of the 
studies.  
This synthesis may have been limited by the search terms used, in that when 
attempting to start from a position of examining all available qualitative research and 
then applying inclusion and exclusion criteria, it is possible that some studies are not 
captured. Broad search terms were used here to attempt to capture as much qualitative 
research relating to PLGBT as possible, however it is difficult to say with certainty 
that all available information was captured, both in regards to variations of qualitative 
methodology used and PLGBT morphology.  
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When considering psychological and emotional wellbeing it is also important 
to consider the authorship and intended focus of the papers utilised in this synthesis. 
Papers conducted by non-psychological/psychiatric professionals, could be argued as 
lacking expertise to conduct research in this area. Additionally where papers had a 
wider focus than just the psychological impact of PLGBT (which was the majority), it 
is questionable as to whether their research design, intent and thus questioning, would 
have led to the most accurate and comprehensive responses for addressing the 
synthesis question. Despite this possible limitation, studies utilised do represent at 
least some aspect of experience for people with a PLGBT and findings are 
representative of the available information.  
Lastly, the studies included here spanned a large time period, with the earliest 
paper published in 1996 and the latest in 2014, with the majority of the papers (9/14) 
from the last five years. The experience of people with a PLGBT from 19 years ago to 
the present day may be significantly different, particularly given current advances in 
treatment protocols (Capatina et al., 2013). This may mean that the results from 
studies published prior to the last few years may not be fully representative of current 
experience, and therefore could have skewed results. However, given the emotive 
nature of brain tumour diagnosis and treatment, the potential for psychological and 
emotional difficulties remains pertinent, regardless of advances in treatment. It is 
possible that as treatment and outcomes change, there will be concurrent changes in 
the way that emotional and psychological issues are experienced and discussed, and 
this is worthy of attention. Additionally, the evolutionary and sometimes 
revolutionary nature of medical intervention may cause both positive and negative 
psychological phenomena for people with brain tumour. The hope for new and better 
treatments and support could be seen as a source of anxiety as people wait for help 
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which may never come, or as a source of hope as they look towards an uncertain 
future and complex recovery process.  
Clinical implications and recommendations  
 This research highlights the need for attention to be paid to the psychological 
wellbeing of people with a PLGBT. Results stress the importance of the psychological 
and emotional process of change, adjustment and coping to all aspects of a person’s 
life and the need for psychological support occurs in all areas, meaning that it is the 
responsibility of all professionals, from the point of first contact with services, to be 
able to provide some level of psychological support. The most positive psychological 
experiences were drawn from experiences where medical staff were able to provide 
engaged psychological care and understanding during the early stages of diagnosis 
and treatment, rather than exclusively focussing on physical health needs. This 
suggests that it may be helpful for those in clinical practice to more fully explore what 
kinds of psychological support needs their patients have and how these could be best 
met by services. The process of audit and departmental research could be very helpful 
in establishing these needs. Based on this it may be that there are implementable 
changes that could be made (e.g. providing clearer information at different stages). It 
could also result in some areas of psychological support which require more specialist 
input from psychology and neuropsychology professionals. This could be achieved in 
a number of ways, for example clinical psychologists and neuropsychologists could 
facilitate training and education sessions for other professions around the importance 
of psychological care in this population and provide consultation for more complex 
cases of psychological need.  
 These results also suggest a need for flexibility in the approach taken to the 
treatment, psychological care and support of people with a PLGBT. People will likely 
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be subject to a range of emotions towards their treatment and care at different points 
during their experience. This means that professionals will need to be willing to 
explore options and reasons for choices carefully and sensitively. The changes in 
personality and therefore life choices discussed above mean clinicians will need to be 
able to adapt to their patients’ changing needs. This need for flexibility may be 
particularly important when considering the needs of people with PLGBT against 
those with high grade tumours. The results have shown that people with PLGBT may 
be subject to a more fluctuating set of emotions and thought processes, and this may 
require clinicians to be sensitive to subtle changes in psychological support needs. By 
doing this clinicians can help people with PLGBT to recognise the patterns in their 
own psychological wellbeing and behaviour and therefore help them to be more 
prepared. Patient need here could be reasonably easily investigated by services and  
may be open to small but important changes which utilise existing models of support. 
For example some organisations operate a buddy system, whereby PLGBT patients 
are paired with someone else in a similar situation. With some increased focus on the 
psychological change process, patients could learn to recognise warning signs which 
require further input. For more complex input, clinical psychology and 
neuropsychology services may be ideally placed to utilise formulation based 
approaches to help both professionals and patients to understand these dynamic needs. 
MDT case formulation and joint work may be an ideal vehicle for establishing a 
shared and comprehensive understanding of the individual.  
 People with a PLGBT may require significant support to try to find the 
ongoing positive aspects to their lives, and even to tumour diagnosis and treatment. 
This again needs to be the responsibility of all professionals, but perhaps more 
significantly a point for consideration for psychological services. This synthesis 
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demonstrated that, in time, people can often find positive elements of their lives to 
motivate them, and that sometimes even relatively small positives, can help to 
improve psychological wellbeing.  
 Lastly, it may be useful to take the information produced from this synthesis 
and use it to construct, or adapt existing, information leaflets for people with PLGBT. 
This would be particularly helpful in preparing people with a recent diagnosis of 
PLGBT in regards to what psychological and emotional difficulties they might 
experience, and help to validate experiences and encourage discussion from people 
with PLGBT. 
Recommendations for future research  
 A number of areas for potential future research have been highlighted by both 
the results of this synthesis and from its possible limitations. The relatively low 
number of studies focussed solely on the experience of PLGBT and the questions 
raised regarding paper authorship in this area, suggest the need for more general 
qualitative research in this area, particularly studies which focus exclusively on 
psychological wellbeing. The synthesis highlights the myriad of emotional and 
psychological difficulties faced by people with PLGBT, and these warrant clear and 
targeted research. Additionally, if this type of research begins to emerge, it would be 
useful to conduct a further synthesis which utilises only recent research with PLGBT, 
and potentially only research focussed on the psychological experience. In this way a 
potentially purer synthesis could be conducted. Lastly results here suggest it would be 
promising to research an interactional model of change and identity within PLGBT, 
with consideration of the themes and issues arising from this synthesis.  
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Table 1 - Inclusion and Exclusion Criteria 
Inclusion Criteria Rationale  
1. Must utilise qualitative methodology as 
the main approach to research 
The purpose of this review is to systematically examine qualitative literature, therefore only papers 
utilising a qualitative methodology will be included.  
2. Must have conducted research with adults 
with a low grade brain tumour  
This review is concerned with examining literature for adults with a low grade brain tumour. The 
studies must include the direct experience of the adult with a tumour (not just relatives or carers, nor 
child studies).  
3. Must discuss, at least in part, the topic of 
psychological wellbeing or the emotional 
impact of having a brain tumour 
This review is concerned with the emotional effects of being a person with a brain tumour. Therefore 
papers must include these issues.   
4.  Published in a peer reviewed journal This allowed for a basic level of quality assurance within the papers. 
5. Published in English. No resource was available for the translation of papers not published in English. 
Exclusion Criteria Rationale 
1. Papers that focus on an single event such 
as a particular episode of treatment or 
surgery  
 
2. Papers that are only loosely or tangentially 
related to the topic  
 
 
3. Papers that examined mixed types of 
cancer or brain metastases 
 
As the review is interested in the broad psychological and emotional consequences of having a brain 
tumour, research that focuses on a specific event, particularly those that could produce extraordinary 
levels of emotion may skew results.  
 
Some papers could be loosely defined as relating to psychological wellbeing, such as issues of 
spirituality. However if these have been examined in isolation from the broader experience, they may 
confuse results.   
 
This review is concerned only with the specific issues related to people with a brain tumour. Any 
studies which include cancer in other locations, or cancer originating elsewhere may confuse results. 
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Table 2 – Characteristics of papers included in the meta-synthesis  
Study  
No 
Authors, date &  
country of origin 
Recruitment 
method and 
location  
Sample size & 
participant 
details 
Aim Data collection 
method &timing 
Data Analysis Epistemology 
1 Cavers, 
Hacking, 
Erridge, Morris, 
Kendall & 
Murray (2013) 
UK 
Purposive sample 
recruited through 
neuro-surgical 
centre 
26 Participants 
14 men, 12 
women 
21-76 years 
Range of tumour 
types 
To explore patients and families 
emotional experience of illness, 
information and support needs and 
their impact on adjustment.  
Series participant 
guided 
interviews 
80 Interviews 
over immediate, 
1 month, 2 
month and 6 
month intervals.  
 
Grounded 
theory   
Realist 
2 Cavers, 
Hacking, 
Erridge, 
Kendall, Morris 
& Murray 
(2012) 
UK 
Purposive sample 
recruited through 
neuro-surgical 
centre 
26 Participants 
14 men, 12 
women 
21-76 years 
Range of tumour 
types 
To explore the trajectories of 
physical, social, psychological and 
existential wellbeing during brain 
tumour progression.  
Series participant 
guided 
interviews 
80 Interviews 
over immediate, 
1 month, 2 
month and 6 
month intervals.  
 
Grounded 
theory   
Realist 
3 Cornwell, 
Dicks, Fleming, 
Haines & Olson 
(2012) 
Australia  
Purposive and 
convenience 
sampling from 
brain tumour 
clinic 
9 Participants 
6 men, 3 women  
36-70 years 
Non Malignant 
brain tumour 
To understand the early post-
discharge support services and care 
requirements of individuals with 
brain tumour.  
Semi-structured 
interviews at 2 
weeks and 3 
months post 
surgery.  
 
 
Content 
analysis 
Realist 
4 Edvardsson & 
Ahlstrom (2005) 
Sweden 
Convenience 
Sample recruited 
through a regional 
cancer register 
39 Participants 
27 men, 12 
women 
21-79 years 
Low grade 
glioma 
To describe perceived illness 
related problems and coping 
strategies  in adults with low grade 
glioma 
Single Semi-
structured 
interview of 1-2 
hours.  
Content 
analysis  
Realist 
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5 Edvardsson, 
Pahlson & 
Ahlstrom (2006) 
Sweden 
Convenience 
Sample recruited 
through a regional 
oncology centre 
27 Participants 
18 men, 9 
women 
23-79 years  
Low grade 
glioma 
 
To describe adults’ experience of 
falling ill and being diagnosed with 
low grade glioma 
Semi-structured 
interviews  
Content 
analysis 
Realist 
6 Fox & Lantz 
(1998) 
USA 
 
Convenience 
sample from 
neuro-oncology 
clinic  
23 Participants  
30-70 years 
 Varied tumour 
types 
 
To explore brain tumour patients’ 
experience of quality of life  
Individual and 
group semi-
structured 
interviews  
Thematic 
analysis  
 
7 Gurel, Bruening, 
Rhodes & 
Lomax (2014) 
USA 
Online and 
advertisement 
recruitment across 
various sites  
19 Participants  
7 men, 12 
women 
Mean age 41 
Acromegaly 
resulting from 
pituitary tumour 
 
To understand the impact of 
acromegaly on patients’ lives from 
their own perspectives 
Individual and 
group interviews 
Qualitative 
categorisation 
of responses  
 
8 Hayhurst, 
Mendelsohn & 
Bernstein (2010) 
Canada 
Convenience 
sample recruited 
from authors 
client list  
 
 
 
24 Participants 
21-82 years  
Low Grade 
Glioma  
 
To explore the impact of low grade 
glioma  
Semi-structured 
interviews 
Grounded 
theory 
Realist 
9 Jagadeesh & 
Bernstein (2013) 
Canada  
Convenience 
sample based on 
authors patients  
32 participants 
18-76 years 
8 men, 24 
women 
Incidental 
tumour 
 
To better understand patients’ 
experience of incidental brain 
tumour findings 
Semi-structured 
interviews 
Thematic 
analysis  
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10 Janda, Eakin, 
Bailey, Walker 
& Troy (2005) 
Australia 
Convenience 
sample from local 
brain tumour 
support service  
36 participants 
11 men, 25 
women 
27-83 years 
Various tumour 
types 
 
To explore the experience of 
support services of patients with a 
brain tumour  
Focus groups 
and structured 
interviews 
Modified, 
structured 
thematic 
analysis 
 
11 Leavitt, Lamb & 
Voss (1996) 
USA 
Convenience 
sample of existing 
support group  
78 participants 
36 men, 42 
women 
Various tumour 
types  
 
To describe the experiences and 
needs of brain tumour patients as 
established in support groups 
Analysis of 
existing 
recording of 
support groups 
over 6 months  
Grounded 
theory 
Realist 
12 Molassiotis, 
Wilson, 
Brunton, 
Chaudhary, 
Gattamaneni & 
McBain (2010) 
UK 
 
Convenience 
sample from 
specialist 
oncology centre 
9 participants 
(with decrease 
over time) 
33-73 years 
7 men, 2 women  
Mixed tumour 
types 
To understand the symptom 
experience and impact of symptoms 
in daily life of brain tumour patients 
Semi-structured 
interviews  
Content/ 
framework 
analysis 
Realist 
13 Ownsworth, 
Chambers, 
Hawkes, Walker 
& Shum (2010) 
Australia 
Purposive sample 
from neuro-
surgical practice 
18 participants 
10 men, 8 
women 
28-71 years 
Mixed tumour 
types 
 
To investigate the personal and 
social process of adjustment in 
brain tumour patients  
Semi-structured 
interviews 
Open and 
selective 
coding 
following by 
synthesis of 
data.  
 
14 Simpson, Heath 
& Wall (2014) 
UK 
Convenience 
sample recruited 
through local 
health care 
professional 
8 participants 
5 men, 3 women 
38-69 years 
Pituitary tumour 
To explore the illness narratives of 
people with a pituitary tumour  
Narrative, open 
interviews  
Narrative 
analysis  
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Table 3 – Appraisal of included studies using the Critical Appraisal Skills programme tool (CASP, 2013) 
No Authors Clear 
Aims 
Qualitative 
methodology 
appropriate 
Appropriate 
research 
design 
Appropriate 
recruitment 
strategy  
Appropriate 
data 
collection  
Relationship 
between 
researcher 
and 
participants 
considered 
 
Ethical 
issues 
considered 
Rigorous 
data 
analysis 
Clear 
statemen
t of 
findings 
Value of 
research  
1 Cavers, 
Hacking, 
Erridge, 
Morris, 
Kendall & 
Murray 
(2013) 
 
Y Y C Y C Y C Y Y Y 
2 Cavers, 
Hacking, 
Erridge, 
Kendall, 
Morris & 
Murray 
(2012) 
 
Y Y C Y Y N C Y Y C 
3 Cornwell, 
Dicks, 
Fleming, 
Haines & 
Olson (2012)  
 
Y Y Y Y Y Y Y Y Y Y 
4 Edvardsson & 
Ahlstrom 
(2005) 
 
 
Y Y C Y Y Y Y Y Y Y 
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5 Edvardsson, 
Pahlson & 
Ahlstrom 
(2006) 
 
Y Y C Y Y C Y Y Y Y 
6 Fox & Lantz 
(1998)  
 
Y Y C Y Y N C Y Y Y 
7 Gurel, 
Bruening, 
Rhodes & 
Lomax 
(2014) 
 
Y Y C Y Y N Y N Y Y 
8 Hayhurst, 
Mendelsohn 
& Bernstein 
(2010) 
 
Y Y C Y Y N Y Y Y Y 
9 Jagadeesh & 
Bernstein 
(2013)  
 
Y Y C Y Y N Y Y Y Y 
10 Janda, Eakin, 
Bailey, 
Walker & 
Troy (2005) 
 
Y Y Y Y Y N Y Y Y Y 
11 Leavitt, Lamb 
& Voss 
(1996) 
 
 
 
 
 
Y 
 
Y 
 
C 
 
Y 
 
Y 
 
N 
 
C 
 
Y 
 
Y 
 
Y 
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12 Molassiotis, 
Wilson, 
Brunton, 
Chaudhary, 
Gattamaneni 
& McBain 
(2010) 
Y Y Y Y Y Y Y Y Y Y 
13 Ownsworth, 
Chambers, 
Hawkes, 
Walker & 
Shum (2010) 
 
Y Y Y Y Y N Y Y Y Y 
14 Simpson, 
Heath & Wall 
(2014) 
Y Y Y Y Y N Y Y Y Y 
Y = Yes 
N= No 
C = Can’t tell  
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Table 4 – Summary of study findings included in the Meta-Synthesis 
No Authors Main Findings 
1 Cavers, Hacking, 
Erridge, Morris, 
Kendall & Murray 
(2013) 
 
Theme 1: Distress anxiety and worry 
Theme 2: Variations and timing of information preferences 
Theme 2: The importance of reassurance, support and hope  
2 Cavers, Hacking, 
Erridge, Kendall, 
Morris & Murray 
(2012) 
 
Theme 1: Dynamic psychological trajectory 
Theme 2: Dynamic existential trajectory  
3 Cornwell, Dicks, 
Fleming, Haines & 
Olson (2012)  
Theme 1: Unmet support needs 
Theme 2: Role changes 
Theme 3: Relationship changes 
Theme 4: Coming to terms with the reality of brain tumour 
Theme 5: Changes in priorities and perspectives 
 
4 Edvardsson & Ahlstrom 
(2005) 
Theme 1: Memory & cognition  
Theme 2: Emotional states  
Theme 3: Refraining from and avoiding  
Theme 4: Re-evaluating 
Theme 5: Expressing emotions and thoughts  
Theme 6: Struggling  
Theme 7: Maintaining hope 
Theme 8: Accepting  
 
5 Edvardsson, Pahlson & 
Ahlstrom (2006) 
Theme 1: Rapid illness onset  
Theme 2: Prolonged illness onset  
Theme 3: Negative healthcare situations  
Theme 4: Positive healthcare situations  
Theme 5: Negative life-situations consequences  
Theme 6: Positive life-situation consequences  
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6 Fox & Lantz (1998)  Theme 1: The stigma of mind-body illness 
Theme 2: An invasive disease of the self  
Theme 3: Dealing with the medical diplomats  
Theme 4: Quality of life: No substitute for living  
 
7 Gurel, Bruening, 
Rhodes & Lomax 
(2014) 
Theme 1: Path to diagnosis  
Theme 2: Impact of diagnosis  
Theme 3: Taking back control / patient empowerment  
Theme 4: Interaction with HCP’s  
 
8 Hayhurst, Mendelsohn 
& Bernstein (2010) 
Theme 1: Initial devastation followed by acceptance and low anxiety  
Theme 2: Absence of symptoms mitigates anxiety concerning progression  
Theme 3: Anxiety is reduced by trust in the physician  
Theme 4: Quality of life is not affected by the diagnosis, as fear of morbidity from intervention is greater than fear of 
uncertainty  
 
9 Jagadeesh & Bernstein 
(2013)  
Theme 1: A patient’s emotional status over the incidental finding is largely dependent on how they were informed of the news  
Theme 2: Breaking worrisome news is best done in person… but if a patient has a good relationship with their doctor then 
telephone communication is acceptable 
Theme 3: Waiting for neurosurgical consultation is a stressful time without adequate support  
 
10 Janda, Eakin, Bailey, 
Walker & Troy (2005) 
Theme 1: Need for support, but unable to name exactly what kind of support 
Theme 2: Need for information and coping with uncertainty  
Theme 3: Need for support to return to pre-treatment responsibilities or prepare for long-term care 
Theme 4: Need for support to overcome stigma/discrimination  
 
11 Leavitt, Lamb & Voss 
(1996) 
Theme 1: The long haul  
Theme 2: Family life changes  
Theme 3: Telling the story   
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12 Molassiotis, Wilson, 
Brunton, Chaudhary, 
Gattamaneni & McBain 
(2010) 
Theme 1: Neurocognitive symptoms  
Theme 2: Social restrictions  
Theme 3: Renewed perspective in life as a result of heightened awareness of mortality  
Theme 4:Fatalism   
Theme 5: Social contacts   
Theme 6: expectations  
 
13 Ownsworth, Chambers, 
Hawkes, Walker & 
Shum (2010) 
Theme 1: What is going on here?  
Theme 2: What does this mean for me  
Theme 3: How things will be vs how things actually were   
Theme 4: What could have been?  
Theme 5: What does the future hold?  
 
14 Simpson, Heath & Wall 
(2014) 
Theme 1: Symptoms and diagnosis  
Theme 2: Treatment, hospitalisation and radiotherapy  
Theme 3: Recovery and the impact of the tumour  
Theme 4: Coping with a pituitary tumour  
Theme 5: On-going symptoms and the future  
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Table 5 – Meta-synthesis themes and constituent original study themes   
Author Emotional States Re-evaluating Interaction with 
health care 
professionals 
  
Change and Coming 
to Terms 
The importance of 
reassurance, support 
and hope 
Looking Back vs. 
Looking Forward 
Cavers, 
Hacking, 
Erridge, 
Morris, 
Kendall & 
Murray (2013) 
 
Distress anxiety and 
worry 
 Variations and timing 
of information 
preferences 
 The importance of 
reassurance, support 
and hope 
 
Cavers, 
Hacking, 
Erridge, 
Kendall, 
Morris & 
Murray (2012) 
Dynamic 
psychological 
trajectory (sub theme 
1: anxiety and stress 
during diagnosis. Sub 
theme 2: Anxiety 
lessening through 
treatment period. Sub 
theme 3: Anxiety 
about life expectancy 
and loss of control, 
uncertainty )  
 
 
 
 
 
 
 
 
  Dynamic 
psychological 
trajectory 
 
Dynamic existential 
trajectory 
 
  
Cornwell, 
Dicks, 
Fleming, 
   Coming to terms with 
the reality of brain 
tumour  
Unmet support needs   
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Haines & 
Olson (2012)  
 
Role changes  
 
Relationship changes  
 
Changes in priorities 
and perspectives  
 
 
 
 
 
Edvardsson & 
Ahlstrom 
(2005) 
Memory & cognition 
 
Emotional states  
 
Expressing emotions 
and thoughts  
 
Re-evaluating   Accepting  Maintaining hope Refraining from and 
avoiding  
 
Struggling  
Edvardsson, 
Pahlson & 
Ahlstrom 
(2006) 
Rapid illness onset  
 
Prolonged illness 
onset  
Positive healthcare 
situations  
 
Positive life-situation 
consequences  
 
 
 
Negative healthcare 
situations  
Negative life-
situations 
consequences  
  
Fox & Lantz 
(1998)  
The stigma of mind-
body illness 
 
 
 
 
 
 Dealing with the 
medical diplomats  
  An invasive disease 
of the self 
 
Quality of life: No 
substitute for living 
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Gurel, 
Bruening, 
Rhodes & 
Lomax (2014) 
Path to diagnosis  
 
Impact of diagnosis  
 
Taking back control / 
patient empowerment 
  
 Interaction with 
HCP’s  
   
Hayhurst, 
Mendelsohn & 
Bernstein 
(2010) 
Initial devastation 
followed by 
acceptance and low 
anxiety 
 Anxiety is reduced 
by trust in the 
physician 
 
Absence of 
symptoms mitigates 
anxiety concerning 
progression 
 
 
  Quality of life is not 
affected by the 
diagnosis, as fear of 
morbidity from 
intervention is 
greater than fear of 
uncertainty 
Jagadeesh & 
Bernstein 
(2013)  
  A patient’s emotional 
status over the 
incidental finding is 
largely dependent on 
how they were 
informed of the news 
 
Breaking worrisome 
news is best done in 
person… but if a 
patient has a good 
relationship with 
their doctor then 
telephone 
communication is 
acceptable 
 
 
 Waiting for 
neurosurgical 
consultation is a 
stressful time without 
adequate support 
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Janda, Eakin, 
Bailey, Walker 
& Troy (2005) 
    Need for support, but 
unable to name 
exactly what kind of 
support 
 
Need for support to 
overcome 
stigma/discrimination 
 
Need for information 
and coping with 
uncertainty  
 
Need for support to 
return to pre-
treatment 
responsibilities or 
prepare for long-term 
care 
 
 
Leavitt, Lamb 
& Voss (1996) 
 
 
 
Telling the story    Family life changes   The long haul  
Molassiotis, 
Wilson, 
Brunton, 
Chaudhary, 
Gattamaneni & 
McBain (2010) 
  
 
 
Neurocognitive 
symptoms 
 
Social restrictions  
 
Fatalism  
Renewed perspective 
in life as a result of 
heightened awareness 
of mortality 
 Social contacts   expectations  
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Ownsworth, 
Chambers, 
Hawkes, 
Walker & 
Shum (2010) 
What is going on 
here?  
   How things will be 
vs how things 
actually were  
What does this mean 
for me  
 
What could have 
been?  
 
What does the future 
hold?  
 
Simpson, 
Heath & Wall 
(2014) 
Symptoms and 
diagnosis  
 
Treatment, 
hospitalisation and 
radiotherapy  
 
Recovery and the 
impact of the tumour 
  Coping with a 
pituitary tumour  
 On-going symptoms 
and the future  
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Figure 1 – Map of meta-synthesis themes and interactions 
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Appendix 1-A – Search Flow Diagram and Inclusion / Exclusion Detail  
 
Article Inclusion / Exclusion Flow Diagram  
Numbers accurate as of 14/12/2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The initial screen (removing 1860 studies) was conducted using the inclusion criteria and subsequent 
removals were a combination of the inclusion and exclusion criteria. During the initial screen the vast 
majority of papers were removed as they were not qualitative studies and a small number were 
removed as they were focussed solely on work with children. The peer review and English language 
Records identified through database 
searching  
(n = 1957) 
PubMed/Medline (n = 1113) 
CINAHL%(n%=%88)%
PsycInfo%(n=154)%
Academic%Search%Complete%(n=602)%
Additional records identified 
from manual searching of 
references 
(n = 2) 
Full-text articles assessed 
for eligibility  
(n = 97) 
Records screened  
(n = 1957) 
Records excluded               
including duplicates 
removed  
(n = 1860) 
Medline (n = 803) 
CINAHL (n = 85) 
PsycInfo (n=133) 
Academic Search 
Complete (n=473) 
%
Studies found to be 
suitable  
(n = 12) 
Full-text articles excluded, 
with reasons upon initial 
examination  
(n = 70) 
Studies included in 
qualitative synthesis 
(n = 14) 
Full-text articles excluded, 
with reasons upon detailed 
examination  
(n = 27) 
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inclusion criteria were already in place as part of the search criteria for each database. Following this 
an initial sift of 97 full text articles was done to assess for suitability, the majority of those excluded 
here met exclusion criteria of either focussed on a single treatment event such as surgery or being 
studies of brain metastases. Detailed examination of full text articles led to a number of exclusions 
based on the paper either not meeting the inclusion criteria of discussing psychological or emotional 
impact (for example being entirely based on the financial impact) or being only tangentially related 
(for example being focussed only on spirituality). Those considered loosely or tangentially related 
were considered in detail, to see if part of their findings could be included (as was done with some 
articles which include mixed social and psychological elements), however in a small number of cases 
this was not possible and thus the articles were excluded.  
 
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
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Appendix 1-B – Full Search Terms  
The search terms used for a final free text search were as follows:  
qualitative OR "focus group" OR "IPA" OR "interpretative phenomenological 
analysis" OR "grounded theory" OR narrative OR "discourse analysis" OR "thematic 
analysis" OR "content analysis" OR Ethnograph* OR Phenomenolog* OR Hermeneutic AND 
brain tumour OR pituitary OR brain cancer OR brain neoplasm OR intracranial neoplasm 
OR Acoustic neuroma OR Adenoma OR Astrocytoma OR Chondroma OR Chondrosarcoma 
OR Chordoma OR Craniopharyngioma OR Ependymoma OR Esthesioneuroblastoma OR 
Glioma OR Ependymoma OR Glioblastoma OR Hemangiopericytoma OR Meningioma OR 
Neurofibroma OR neuroblastoma OR Oligodendroglioma OR Osteoma OR Pituitary tumor 
OR “Rathke’s cleft cyst” OR Rhabdomyosarcoma OR “Skull base tumour” OR “vestibular 
schwannoma” 
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Appendix 1-C – Author guidelines for chosen publication journal  
 
Journal of Neuropsychology 
© The British Psychological Society 
 
Edited By: Stephen Jackson 
Impact Factor: 3.818 
ISI Journal Citation Reports © Ranking: 2013: 7/83 (Psychology Experimental); 14/74 
(Psychology) 
Online ISSN: 1748-6653 
Author Guidelines 
The Journal of Neuropsychology publishes theory-driven patient studies. The central brief is 
to learn more from patients with brain dysfunctions to gain a better understanding of brain-
behaviour relationships and to help future patients. Important developments in 
neuropsychology will follow from a multidisciplinary approach embracing neighbouring 
fields such as developmental psychology, neurology, psychiatry, physiology, endocrinology, 
pharmacology and imaging science. The journal publishes group and case studies addressing 
fundamental issues concerning the cognitive architecture of the brain. In addition, the journal 
includes theory-driven studies regarding the epidemiology of specific deficits, new 
assessment tools, and the evaluation of treatment regimes.  
The journal is committed to a fast and efficient turn-around of papers, aiming to complete 
reviewing in under 90 days. Submissions are processed via a web-based system and 
reviewers are required to complete their referee report within 28 days.  
Papers will be evaluated by the Editorial Board and referees in terms of scientific merit, 
readability, and interest to a general readership.  
1. Quality Control  
The content, format, quality and ambition of the JNP as a major outlet for theory-driven 
neuropsychological studies is under constant review by the Consulting Editors:  
• Kenneth M. Heilman (University of Florida College of Medicine, Gainesville, USA)  
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• Donald T. Stuss (Rotman Research Institute, Baycrest, University of Toronto, Canada)  
• Giuseppe Vallar (University of Milan-Bicocca, Italy)  
• Elizabeth Warrington (National Hospital for Neurology and Neurosurgery, London, UK)  
2. Circulation  
The circulation of the Journal is worldwide. Papers are invited and encouraged from authors 
throughout the world.  
3. Paper formats and length  
Research papers are full-length reports of original scientific investigations. Papers should 
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How do People with a Pituitary Tumour Experience Cognitive Difficulties and 
Neuropsychological Testing?  
 
Abstract  
Pituitary tumours make up around 10% of brain tumour diagnoses in the UK. The condition 
itself alongside treatment can have a significant impact, including on cognitive function and 
psychological wellbeing, often resulting in an impaired quality of life for the individual and 
their family / social networks. Cognitive function makes up only part of most quality of life 
research, and the experience of neuropsychological testing for these difficulties is particularly 
under-researched. This study examines qualitatively the experience of people with a history 
of pituitary tumour, focussing on cognitive difficulties and subsequent neuropsychological 
testing. Seven semi-structured interviews were conducted and analysed using Interpretative 
Phenomenological Analysis. Six final themes emerged: (1) My brain just is not working; (2) 
Invisible but debilitating; (3) I thought I would be cured, more support and understanding are 
needed; (4) Neuropsychological testing is hard but important; (5) Life will never be the same; 
(6) Learning to cope. These are examined in relation to existing literature and clinical 
implications, limitations, and directions for future research are discussed.  
 Keywords: pituitary, tumour, cognitive, neuropsychology, interpretative 
phenomenological analysis  
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Introduction 
Approximately 16,000 people are diagnosed with a brain tumour each year in the UK 
(Brain Tumour Research, 2015), pituitary tumours making up approximately 10% of 
diagnoses (Macmillan, 2015). The majority of pituitary tumours are benign adenomas, 
commonly comprising prolactinoma, Cushing’s disease, acromegaly and non-functioning 
pituitary tumours (Fernandez, Karavitaki, & Wass, 2010). 
Pituitary tumour diagnosis has an estimated prevalence rate of 75-100 per 100,000 in the 
general population (Daly et al, 2006; Gruppetta, Merciecca & Vassallo, 2013 & Fernandez, et 
al., 2010). A systematic review by Ezzat et al. (2004), utilising autopsy and incidental 
discovery statistics, estimated an overall prevalence of 16.7% (16,700 per 100,000). This 
difference in statistics may represent the under-diagnosis of pituitary tumours or a lack of 
people with more minor symptoms seeking support  
One of the distinctive features of pituitary tumours, compared to other types of brain 
tumour, is production of excess hormones and disruption to ordinary hormone production and 
regulation in the brain1. This can lead to many potential physical, psychological and cognitive 
effects (See Appendix 2-A), particularly problems with memory and executive function 
(Peace, Orme, Padayatty, Godfrey & Belchetz, 1998; Tooze, Gittoes, Jones & Toogood, 
2009). The location of larger pituitary tumours near the base of the skull can create pressure 
on nerve and artery function in the brain, increasing the likelihood of surgical complications 
(Nakase et al., 1994; Liu et al., 2011). The proximity of the pituitary gland to the optic 
chiasm can result in problems with vision (Freda, 2011; Tanemura et al., 2012). All these 
factors can impact on the quality of life (QoL) of patients2.  
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
1$Prolactinoma$affects$prolactin$(a$hormone$linked$to$sexual$and$reproductive$functions)$
$Cushing’s$Disease$affects$cortisol$(a$hormone$linked$to$stress,$metabolism$and$immune$responses)$
$Acromegaly$affects$human$growth$hormone$(a$hormone$linked$to$cell$production$and$growth)$
2$Patient$in$used$in$this$paper$to$reflect$both$the$common$medical$environment$around$pituitary$tumour$and$
the$chosen$language$use$of$participants$during$interviews.$$
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 QoL measures used in pituitary tumour either pre-treatment or in groups not requiring 
treatment, have found decreased QoL levels in areas such as physical functioning, bodily 
pain, vitality, anxiety, depression and social functioning (Johnson, Woodburn & Vance, 
2003; van der Klaauw, Biermasz, Hoftijzer, Pereira & Romijin, 2008; Page, Hammersley, 
Burke & Wass, 1997; Tooze et al., 2009), suggesting that with or without treatment 
intervention, people with a pituitary tumour are at significant risk of a decreased QoL.  
Several studies have evidenced that both surgical (Milian, Honegger, Gerlach & 
Psaras, 2013; Tanemura et al., 2012) and radiological (Page et al., 1997; Dyer et al., 2014) 
interventions can have a significant negative impact on QoL, worsening those potentially 
affected areas described above. Reductions in QoL may have a relatively short recovery 
period of one to six months (Milian, Honegger, Gerlach & Psaras, 2013; Tanemura et al., 
2012) and a recent study by Capatina et al. (2013) suggested current treatment protocols can 
offer normal levels of QoL following intervention. Capatina et al. suggest that advancing 
surgical techniques and post-operative hormone replacement therapies offer a previously 
unachievable QoL for patients. However, their study examined only patients with non-
functioning adenoma; further research would be needed to examine if current practices lead 
to similar improvements across all pituitary tumour types. Treatment developments 
potentially mean that experiences described in quantitative and qualitative studies more than 
a few years old, may not be representative of current experience. More up to date research is 
needed in order to elucidate current patient experience.  
One aspect of QoL that has received significant attention is cognitive function 
following intervention (e.g. Brummelman et al., 2011; Noad, Narayanan, Howlett, Lincoln & 
Page, 2004; Tooze et al 2009). Surgery and radiotherapy have both been investigated for their 
effect on cognitive function. Evidence suggests that surgery can have a significant impact, 
particularly in areas of memory, attention, concentration and possibly executive function 
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(Guinan, Lowy, Stanhope, Lewis & Kopelman, 1998; Peace et al., 1997; Peace et al., 1998). 
Evidence for radiotherapy is more complex, some studies finding that radiotherapy (both 
alone and when paired with surgery) has no appreciable impact on cognitive function 
(Brummelman et al., 2011; Brummelman et al., 2012; Peace et al., 1998; Van Beek et al., 
2007). Other sources have found significant cognitive impairment as a result of radiotherapy 
(McCord et al., 1997; Guinan et al., 1998; Noad, et al., 2004).  
Much research surrounding patients with a pituitary tumour has utilised quantitative 
methodology, and may overlook contextual and experiential detail. A small number of 
qualitative studies of experience have been conducted, and all show common themes: loss, 
changes to self-identity, lack of control, long, difficult journeys to diagnosis, lack of trust in 
health care professionals and shock at various stages (such as needing surgery) (Gurel, 
Bruening, Rhodes & Lomax, 2014; Morris & Jackson, 2007; Simpson, Heath & Wall, 2014).  
These themes could apply to many types of brain tumour, however some of the 
specifics within them form the overall distinctive pattern of pituitary tumour experiences. For 
example, the consistent discussion of how difficult it is to get a diagnosis (Gurel et al., 2014; 
Morris & Jackson, 2007; Simpson et al., 2014), and the idea that once a pituitary tumour has 
been removed and hormones stabilised, patients will have no further difficulties (Morris & 
Jackson, 2007). Additionally, the notion that if difficulties are raised, they will be seen as 
transient by healthcare professionals and thus patients learn to say nothing (Gurel et al., 
2014).  
Some qualitative results included experiences of cognitive difficulties, particularly in 
regard to subsequent personal and interpersonal difficulties. For example, the idea that 
inhibition was impaired, leading to more childlike, socially inappropriate behaviour (Simpson 
et al., 2014). However, none of the papers examined neuropsychological services’ 
involvement with pituitary care. The notion of shock around emerging difficulties, 
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particularly psychological and cognitive difficulties, is prevalent. Participants report few 
expectations of these difficulties (by them or their healthcare professionals) (Morris & 
Jackson, 2007; Simpson et al., 2014) which can lead to a lack of support and communication 
(Gurel et al., 2014; Morris & Jackson, 2007) 
 Regardless of cause, level of impact or statistical prevalence, the quantitative and 
qualitative evidence above demonstrates that cognitive function is a key issue in the 
experience of pituitary tumour. The core functions of neuropsychological assessment are to 
aid diagnosis and treatment planning by providing measurement of cognitive function and 
assessment of complex cognitive difficulties (Lezak, Howison, Bigler & Tranel, 2012, pp 4-
5), yet patients’ experience is not discussed in any paper examined above.  
Neuropsychological testing in pituitary tumour uses various standardised tests to 
measure cognitive functions, covering global functioning, and specific areas at risk as a result 
of pituitary tumour and subsequent intervention (e.g. memory and executive functioning). 
These tests can be used as measures of pre- and post-operative ability, or used only in post-
operative circumstances where there is concern. Usage is largely down to the protocols of 
individual departments, and resources available.  
 Little information is available regarding the experience of people undergoing 
neuropsychological testing, in pituitary tumour or other types of brain tumour research. An 
unpublished thesis by Owen (2012) highlighted that people with a traumatic brain injury 
often gained significant insight into their own cognitive difficulties as a result of 
neuropsychological assessment; participants were divided between those who were aware of 
difficulties and those unaware, but both groups found testing an informative process in regard 
to their care and wellbeing. Bennett-Levy, Klein-Boonschate, Batchelor, McCarter & Walton 
(1994) explored the experiences of patients who had undergone neuropsychological testing 
after a variety of acquired brain injuries, participants gave qualitative statements, but those 
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statements were subsequently coded into quantitative data. Of their participants, 91% found 
the experience of neuropsychological assessment a positive or neutral one. Some found the 
process tiring and frustrating, and overall perception of testing was linked to how useful the 
feedback of results was. Thirty two percent of participants reported having received no 
feedback. Westervelt, Brown, Tremont, Javorsky & Stern (2007) approached 349 patients 
with mixed neurological diagnoses and 218 significant others with open ended questionnaires 
about neuropsychological testing, with a 37% return. They collated qualitative responses and 
examined these for trends. Results showed a positive reaction to the assessment experience, 
but a more negative reaction to practical issues such as the room they were assessed in. 
However, the study did not anonymise surveys, potentially leading to some bias amongst 
responses.  
 The paucity of literature regarding neuropsychological testing experience in people 
with a brain tumour, and limited but complex findings from related neurological fields, 
means that exploring the individual experiences of patients may be helpful in developing 
neuropsychological services further. The demonstration of some of the distinct aspects of 
pituitary tumour patients (e.g. prevalence, hormonal impact, expectations) in the above 
sections highlights how their experience could be different to other forms of tumour and 
neurological condition. This suggests that exploring neuropsychological testing experience 
and cognitive difficulties in this population may be of value in designing and targeting 
specialist services, and better understanding the lived experience of patients and their 
interaction with services.  
The Present Study  
 The present study sought to examine gaps in research related to the qualitative 
experiences of people with pituitary tumours, with particular emphasis on the cognitive 
difficulties and neuropsychological testing. Both areas currently display paucities of research 
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compared with the body of quantitative evidence for overall QoL and treatment options for 
people with a pituitary tumour. By examining these areas using individual interviews, it was 
hoped a better understanding of lived and shared experience could be gained.  
Methodology 
Design 
This study used a qualitative design employing Interpretative Phenomenological Analysis 
(IPA) methods (Smith, 1996) to explore the experience of cognitive decline and 
neuropsychological assessment in people with a pituitary tumour. IPA was used to explore 
how patients understand and make sense of their experiences of cognitive difficulties and 
neuropsychological testing.  
Ethical Considerations  
Ethical Approval was sought through the Integrated Research Application System and 
granted by a local Research and Ethics Committee. The study was approved and insured by 
Lancaster University. Full documentation regarding ethical approval can be found in the 
ethics section.  
Participants and Recruitment  
 Participants were recruited according to specific inclusion and exclusion criteria. 
Inclusion criteria were the experience of a pituitary tumour and the experience of formal 
neuropsychological testing. Initially it was hoped to have only participants who had 
undergone testing in the last 12 months, however this was not possible due to recruitment 
numbers. The only exclusion criterion was a significant communication difficulty that would 
compromise understanding and participation. Participants were recruited from a National 
Health Service (NHS) site, local and national charitable organisations and via social media. 
Pituitary tumour may represent a small sample of people involved in the various 
organisations used to recruit. In order to provide the best possible anonymity for participants, 
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information about which organisations were approached, recruited from and in what 
numbers, will not be presented here. A process diagram for recruitment can be found in 
Figure 1. All participants gave fully informed consent, and were given pseudonyms and 
anonymised during the study. 
-------------------------------------------------------------------------------------- 
Insert Figure 1 Here 
--------------------------------------------------------------------------------------- 
 An important part of IPA research involves finding homogeneity in the sample of 
participants (Smith, Flowers & Larkin, 2009). Homogeneity requires finding participants who 
have shared similar experiences, for whom the research question will be meaningful (Smith, 
et al., 2009), sometimes this will involve sharing demographics, but not always. Here, given 
pituitary tumour prevalence rates, demographic homogeneity was not appropriate and shared 
experience more important.  
  Specific demographic information is not presented here to protect anonymity. 
However, participants were Caucasian and between the ages of 18 and 65, and included men 
and women. All participants had adult onset pituitary tumours, but subsequent medical 
complications varied across participants.  
Data Collection  
 All data was collected using semi-structured interviews, arranged in accordance with 
participants’ wishes. Where the researcher went to the home of a participant, this was done in 
accordance with the Lancaster University lone working policy (Lancaster University, 2007).  
 Interviews followed the interview schedule (see ethics section), designed to allow 
participants to explore freely any issues relating to cognitive difficulties associated with their 
tumour, followed by their experiences of neuropsychological assessment. The schedule was 
devised after examination of relevant literature and consultation with the academic and field 
supervisors. The schedule was not used in an exact order, and some items were not asked 
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explicitly as the participant covered the information in other answers. Some of the discussion 
was expected to be not relevant to the issues of cognitive difficulties and neuropsychological 
testing; however discussion of wider issues may have led to more specific discussion of these 
areas.  
 Interviews lasted between 40 and 90 minutes, averaging 65 minutes. Each interview 
was completed in one session, at the request of participants. Interviews were digitally 
recorded and transcribed verbatim within two weeks of the interview date.  
Data Analysis  
 IPA was used to analyse all interview data. IPA is a flexible methodology, allowing 
the researcher a degree of freedom in adapting the style of analysis (Cronin & Lowes, in 
press; Smith, 1996; Smith et al., 2009) to suit circumstance and personal preference. For this 
research each transcript was examined individually, and then all superordinate themes from 
all transcripts were brought together to form final themes. This ensured that all participants’ 
data was equally weighted, and reduced the possibility of preconceived ideas of themes 
effecting data extraction. The process followed a path from initial reading of the data to 
examination of final, cross-participant themes. A summary of the steps involved can be found 
in Box 1 (please see Appendix 2-B for an example of a coded transcript).  
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Box 1. – Based on process outlined by Smith et al. (2009, p. 82-106) 
Step 1 – Immersion in initial data – The researcher reads and re-reads a transcript until 
they feel familiar with the data. The researcher also listens to the audio recording 
alongside reading the transcript at least once, in order to ensure the participant and their 
interpretations remains at the forefront of the researcher’s thought process.  
Step 2 – Initial Notations – The researcher begins to note initial thoughts, ideas and 
points of interest directly on to a transcript as they read. No restrictions are placed on 
what can be noted. Notes will encompass descriptive comments (highlighting the actual 
detail of what was said), linguistic comments (examining specific language use) and 
conceptual comments (more interrogative, reflective ideas about the data).  
Step 3 – Emergent Themes – The researcher uses the notations made and their 
knowledge of the data to begin to group together comments, reducing the volume of 
information whilst maintaining complexity.  
Step 4 – Bringing together emergent themes – The researcher begins to draw together 
emergent themes to form clusters of related themes, which are finalised into the major 
emergent themes for a participant’s data.  
Step 5 – Exploring themes across participants – After the above 4 steps have been 
conducted for each data set, the researcher can begin to create super-ordinate themes for 
the entire data set.  
 
Ensuring Methodological Rigour3 
I adopted a reflexive approach to this research, and acknowledge that my own 
perspective was likely to influence my interpretation of data (Elliott, Fischer and Rennie 
(1999). This is in line with IPA’s double hermeneutic involvement concept, whereby the 
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
3$This$section$is$written$in$the$first$person$to$ensure$accuracy$in$understanding$for$the$reader$
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researcher is actively engaged in interpreting and understanding the participant as they try to 
make sense of their own experiences (Smith, et al., 2009 pp. 3). By recognising this, I hoped 
to improve transparency and rigour. I reflected throughout on my own influences and ideas 
about practice and research in this area and with this population. This helped to inform my 
decisions at each stage and allowed me to recognise issues I could take to my academic and 
field supervisors for discussion.  
 I involved my academic supervisor in the early stages of this process, in an attempt to 
ensure quality and robustness in my work. My use of verbatim quotations in the results 
section helps to demonstrate transparency in theme development, and a full paper trail 
(Yardley, 2008, p. 243) is available showing the journey from raw data to final themes.  
 I adopted a realist social constructionist (Elder-Vass, 2012) epistemology, and this 
related closely to the IPA epistemology which is traditionally based in both social 
constructionism and critical realism. I believed that each participant would construct their 
own meaning in relation to the topics they discussed, and wished to help them explore this. 
However, I also appreciated the influence of the outside world and wider (e.g. social) 
structures on experience.  
Results 
The interpretative phenomenological analysis generated six final themes: (1) My brain 
just is not working; (2) Invisible but debilitating; (3) I thought I would be cured, more 
understanding and support are needed; (4) Neuropsychological testing is hard but important; 
(5) Life will never be the same; (6) Learning to cope.  
A summary of each final theme resulting from the analytic process and its constituent 
superordinate themes is represented in Table 1. 
-------------------------------------------------------------------------------------- 
Insert Table 1 Here 
--------------------------------------------------------------------------------------- 
2"13$
EXPERIENCES OF PEOPLE WITH A PITUITARY TUMOUR 
$$
Figure 2 represents a diagrammatic map view of how the final themes interact, 
discussed further during the results and discussion section.  
-------------------------------------------------------------------------------------- 
Insert Figure 2 Here 
--------------------------------------------------------------------------------------- 
Theme 1: My brain just is not working 
...it’s just too much, annoying, frustrating, quite crushing to be honest, it’s just too 
much information, it’s just not going through … everything just stops (TP4) 
 This theme was universally contributed to by participants and included: a sense that 
the brain is not working the way it should; the direct descriptions of cognitive difficulties 
experienced; the impact on mood; and how both cognitive problems and mood resulted in a 
cycle of difficulty.  
Participants had noticed their cognitive difficulties in daily living: “I leave my shopping 
bag on the till...bring the teapot up to my mouth...and burn my lips” (TP5). Participants 
reported attempting tasks which previously would have presented no difficulty, but were 
unable to complete them: “I couldn’t put these shelves up, it was a real battle” (TP2).  
A wide range of cognitive problems was reported; most commonly issues with 
memory, attention, concentration and executive functions such as problem solving, inhibition 
and mood regulation. Participants found these difficulties hard to manage and restrictive in 
their daily lives: “Normally [at work] there would be...lots of activity...functionality... 
processing... and...just nada” (TP7). Often the descriptions of specific cognitive functions and 
the understanding of these was drawn from neuropsychological sessions, whilst prior to this 
they only knew that something was not functioning correctly in their brain: “My brain just is 
not working” (TP3).  
Mood was included in this theme because participants responded with mood-based 
difficulties when asked about cognitive difficulties. Mood was seen as both a direct cognitive 
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issue and as intricately linked to the experience of cognitive difficulties, particularly the 
ability to regulate mood, resulting in “mood swings” (TP4) which prevent clear thinking: 
“I’m just not thinking straight, nothing’s working” (TP4).  
Participants described anxiety, depression and general mood difficulties as a result of 
their cognitive problems. They could not enjoy relaxation activities: 
 “I can’t watch the television...I can’t really concentrate on reading a book” (TP1). 
The frustration and upset in being unable to complete tasks, activities and routines was very 
difficult.  
… what’s it like to live with it, depressing... I went through the oh I’m fine … and 
then it just hit rock bottom ... took a long time to get used to the fact that I needed 
psychiatric help ... but now … the anxiety ... that’s the thing that I’m dealing with 
every day (TP6) 
 Cognitive problems and mood also produced a cycle of stress and cognitive decline 
which participants found hard to manage. One participant described this as a “self defeating 
cycle” (TP3), where struggling to complete a task or utilise memory would cause stress, and 
then stress would cause further cognitive difficulty:  
... as a result … [struggling with task] I’ll get very stressed ...the stress of the memory 
not working or the fear that what might happen... causes you more stress, which 
causes you... more inability to remember things (TP3) 
 The experience of cognitive difficulty and the resultant cycle of stress were linked in 
later discussion to the neuropsychological testing process. Participants noted that 
neuropsychological testing results helped them to understand their own cognitive processes; 
they were more able to understand how their brain now functioned, rather than seeing only 
the lack of function.  
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 Its$one$of$the$most$important$documents$that$I$have$for$helping$me$understand$
(TP7) 
Theme 2: Invisible but debilitating 
I could see it happening, but people … it’s invisible to them. They just see ‘well your 
working fine’ but they don’t see what it’s like inside. (TP7) 
This theme described how the types of cognitive problems described above are often 
invisible to others, but impact on nearly all areas of life. Participants explained that they do 
not always want to have to explain how and why they have difficulty and why they live as 
they do. However, participants felt that if they did not explain, others would negatively judge 
them.  
I don’t necessarily want to tell every person that I meet ... but you can see them sort of 
thinking okay, so why don’t you work....we’re socially conditioned to want respect 
from our peers … and you want to be accepted (TP1) 
 Participants expressed that the impact on them is “debilitating” (TP3). They described 
significant changes to their daily life, ability to work, social contact, self worth, motivation 
and ability to move forward with their lives.  
...the implications of what can happen or what’s going to happen in the future, the 
memory loss seems to be getting worse... you’re thinking have you got Alzheimer’s or 
some other degenerative brain disease (TP3) 
Lastly, some participants explained how hard they work to ensure that others do not 
see them as having difficulties: “...in many respects tried to hide the difficulties” (TP2), or in 
need of help. For some this was about maintaining their sense of independence, or feeling 
other people could not understand, or because they could not tolerate receiving sympathy 
from others: “It’s horrible when people do that sad face, “oh you’ve got a brain tumour, oh 
and they didn’t be able to cut it all out [sic]” (TP6) 
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Theme 3: I thought I would be cured, more understanding and support are needed 
I thought any kind of difficulty I was having functioning was just the recovery process 
and eventually... it became clear...that it was a permanent situation (TP5) 
 This theme encapsulated three closely linked threads of conversation. First, 
participants were unprepared for the cognitive difficulties they experienced: “...it was all new 
to me this cognitive dysfunction, I wasn’t expecting it” (TP5). Second, participants wished 
that professionals knew more about these difficulties: “the doctor’s actually said to me well 
we don’t know, so I had to look things up for myself” (TP1). Lastly, the struggle in 
convincing professionals of their difficulties and accessing support: “you’re constantly being 
put down, as if they’re not hearing what you are saying” (TP7). These three aspects were also 
influenced by the neuropsychological testing experience. Participants were able to use 
neuropsychological test results and subsequent understanding as a form of support and as a 
way to validate their experiences to date.  
All participants said they did not know of the potential for cognitive problems. One 
participant did state that they had been told radiotherapy could cause some cognitive 
deterioration, but had not been given the same warning about surgery, which had caused 
difficulty for them. Participants had different opinions on why this information was not 
given. For some there was a belief that their doctor did not themselves know enough to be 
able to help: “my doctor didn’t really understand” (TP7) Others felt that information is 
deliberately withheld. Sometimes these issues were later discussed with their 
neuropsychologist and whilst this did not always give concrete answers, it did provide an 
outlet for the emotion. One participant was invited to talk to people awaiting surgery for their 
tumour, but was later excluded as they had wanted to advise people of the potential cognitive 
problems.  
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 they asked me would you consider talking to these people … and I was going yeah 
I’ll tell them all about it...they was trying to be positive and I was going “yeah but..” 
and when I did the ‘yeah but’ they then said no we don’t want you to attend (TP4) 
The shared experiences of participants were a sense of shock and depression when 
their cognitive difficulties began to emerge, particularly those following surgery. Participants 
attached all of their hope to the idea of being cured following surgery, an idea reinforced by 
professionals. To then experience cognitive difficulties left them unprepared, and less able to 
cope with the challenges facing them.  
...he said, ‘this will be a cure … this treatment will be a cure’. So to me a cure meant 
I’m not left with any residual problems, I did actually say to him...it would have been 
so helpful ...to have prepared me for this (TP7)  
A number of participants said that their doctor tied all difficulties into hormonal 
imbalances, so that if hormones are balanced, there should be no remaining problems. This 
was not their experience, and caused further distress.  
The medical doctors would always say… you’ve had the tumour removed, you’re 
having all the hormone treatment so you should be fine now, but you don’t actually 
feel like that yourself, you feel that there’s lots of things that you can’t do (TP2) 
Trying to convince professionals of the existence of cognitive difficulties was 
challenging for a number of participants. They would report difficulties, but would be 
dismissed or not listened to: “at best they can sympathise and at worst they can sit there 
looking bewildered and dismissive” (TP5). This process was draining and emotionally 
challenging. Participants discussed the worry that people thought they were making their 
difficulties up, and the stress of fighting for support: “Because I was so fed up of ‘she reports’ 
… as though ‘we don’t believe her’.” (TP7). As discussed later, this process was then often 
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linked to the later feelings of relief when accessing neuropsychological services, which by 
their nature, are there to recognise and provide support for cognitive difficulties.  
The combination of lack of understanding, lack of belief in the reports of the 
participants and lack of resources led to a common description by participants that there is 
little to no support available for them.  
I didn’t get any support ... it’s like... you’re a body that needs to be fixed physically 
...and that’s all they concentrate on … and other than that you’re on your own (TP1) 
This lack of support covered physical, psychological and life management domains, 
and was a significant source of distress and disappointment for participants. 
I used to go to … a meeting of the [charity support group] ... whoever you talk to 
there, they’ve all got basically the same problems … that group’s now gone...that’s a 
shame ... They also provided support for wives, girlfriends … but now there there’s 
been no assistance whatsoever. (TP2) 
Participants expressed a strong desire to access any kind of support that might be 
available to them: “there definitely does need to be some sort of support...I thought I was 
dying” (TP4). Sometimes neuropsychological input (discussed below) was given as a notable 
source of support, but this was short term and its removal caused distress and anxiety.  
I do feel a bit let down now that I’m cut off from all of that [neuropsychology 
services]... it would be very nice if I could have some kind of catch up, follow up...I 
sometimes think that the statement ‘there’s nothing more we can do’...shouldn’t lead 
to being completely cut off from ever being able to talk to someone about it again 
(TP5) 
Theme 4: Neuropsychological testing is hard but important 
This is worth its weight in gold, it meant so much to me. It helped me think ‘I am not 
going mad’...I can’t say enough...for my neuropsychological assessment (TP7) 
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This theme contained participants’ experience of the neuropsychological testing 
process, including accessing neuropsychological services, being tested and the use and utility 
of results. A number of participants described how difficult it was to gain access to a 
neuropsychologist: “...via the endocrinologist and that was a reluctant referral more or less I 
don’t want to deal with this anymore let them deal with you.” (TP5). In some cases the 
participant had had to drive forward the referral, sometimes having to seek out their local 
team themselves as the professionals around them had no knowledge of neuropsychological 
services: “I came back and said look ...I need to see a neuropsychologist, so there’s a very 
good team at...” (TP7). These struggles were exacerbated by the difficulty in convincing 
professionals that their cognitive difficulties existed.  
 After participants had accessed neuropsychological services, their experiences were 
fairly similar, describing a difficult, tiring and energy consuming process, but one which 
ultimately felt worthwhile and provided a measure of understanding around their cognitive 
difficulties.  
She made me feel there’s a light at the end of the tunnel where before there wasn’t, 
you know we’ve found something out, we’ve actually found that the brain is damaged 
(TP4)  
 Participants explained that results helped to validate their own thoughts and feelings, 
as their belief about their cognitive difficulties was finally confirmed. Neuropsychological 
results can also be used to defend themselves when discussing their difficulties with other 
people, including professionals: “Neuropsychological reports...are quite powerful...they don’t 
get questioned really so they are of a big use in that way” (TP5) 
Neuropsychological services were also described as useful in helping to develop 
practical strategies for managing neuropsychological difficulty (described further in the 
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learning to cope theme), however, for some the testing process felt useful at the time, but they 
found it difficult to make use of the results in any meaningful long term way.  
I did feel that I benefitted from going in and having the testing but... it certainly didn’t 
make an impact on changing my life long term...other than I had a better leg to stand 
on when I was arguing ... “I’m not mad I’ve had psychological testing” (TP1) 
Lastly, some felt that neuropsychological testing did not recognise all difficulties. 
This was due to two main issues: firstly that the tests sometimes report that participants are 
within the normal range of abilities, but they feel this is still deterioration from their previous 
abilities: “I didn’t perform particularly well but the results came back yes you know I’m the 
norm, before the operation I was better than the norm” (TP2). Secondly, the intermittent 
cognitive problems experienced mean a single testing event may not capture the peaks and 
troughs of cognitive function.  
I don’t think that really it was able to really show what cognitive difficulties a 
pituitary person would have because...I wasn’t necessarily feeling stressed or upset or 
any of those things (TP1) 
Theme 5: Life will never be the same 
...you are going to give up, because you’re tired and your brain doesn’t work and you 
sit at home and think, ok this is my life then. (TP7) 
This theme was contributed to by all participants, stressing the important role it 
played in the overall experience. For many the journey through diagnosis, treatment, and life 
since was characterised by initial devastation and fear, but continued hope for a full cognitive 
recovery. This theme represents the realisation from participants that their cognitive function, 
and by extension their lives, will never fully return to the way they were: “it just gradually 
dawned on me that nothing ever got better, I think that was a slow shock if you like, it was 
‘this is not getting better is it’ ” (TP5) 
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 Constant comparison to the old self was present, and grief for what had been lost, 
both in terms of lost functioning and abilities, and loss of a potential future.  
… as a child I think I sort of had this … fairly normal idea, I’m going to get married 
by the time I’m 25 and I’m going to have four children and you know, family 
life…My life has been so vastly different from that fantasy…there’s this thought of 
… ‘why am I here now?’, ‘what is my purpose in life?’… I’m not working, I can’t 
have children, you know, I’m not doing … the normal functions of human life. (TP1)  
Participants described emotional turmoil when trying to come to terms with life 
changes. This was often expressed as a rejection of their difficulties, and a determination to 
get back to their lives and previous functioning: “I was so determined I just said look even if I 
just come back [to work] for a little while to prove that I can do it” (TP6) 
The notion of getting back to work was prevalent, with participants attaching a lot of 
their self worth to this. When this proved impossible, it led to feelings of uselessness and low 
self esteem. Work became the focus of anxiety, as even if participants still wanted to work, 
they became too concerned about their abilities to attempt it: “I was supposed to go for a job 
interview...I just don’t have the confidence in my ability... so I withdrew” (TP7) 
For most there was an eventual sense of resignation and acceptance of their 
difficulties: “there’s nothing we can do about it ... just a matter of trying to have a lifestyle to 
fit...and accept it” (TP3). This created low mood, anxiety about the future, but also relief as 
they moved away from the fight to get back to ‘normal’.  
So I’m a little oddity sitting there, trying not to be difficult, trying to just accept it, 
accepting is a …[laughs] an important thing. So we’ve sort of been on a weird journey 
where I kept thinking I can recover and get back to it and I think...I’ve sort of given 
up. (TP7)  
Theme 6: Learning to cope 
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The way I cope with it … just live life on a day to day basis…I can go a long time 
now without trying to think about it … because there is no point (TP1) 
 This final theme encapsulated the ways in which participants were learning to manage 
their cognitive difficulties, and the more positive outlook on the future. Whilst many feel that 
their lives will never be the same, this theme did show hope for managing ongoing 
difficulties and potentially continuing to recover cognitive function. The eventual acceptance 
of difficulties was discussed, but also the ongoing desire to improve and recover. As 
discussed above, neuropsychological testing played a key role in this coping process and 
participants were able to utilise test results and the expertise of their neuropsychologist to 
help them begin to adjust to the changes in their life in a more positive way. However, for 
most neuropsychological results and interactions came quite late to their coping process and 
so other methods were sought over time.  
Participants discussed practical ways that they found to cope, such as managing their 
lack of energy: “… if I worked through lunch ... leave an hour early, that gave me enough 
time to recharge and go in the next day” (TP7) 
 The psychological coping process involved a variety of strategies, often involving 
family and friends as sources of support and motivation: “I had to get back home then, with 
the kids...back round the family for support...” (TP4). Participants described learning to find 
the positives in their situation, such as thinking how much worse things could have been, and 
moving away from locating blame.  
... because the operation had done such good in saving my sight I certainly couldn’t 
look upon it as something that shouldn’t have been done, I don’t think the surgeon 
made any mistakes at all (TP5).  
Participants found comfort and positive experiences in finding new ways to use their 
time, such as in new activities and hobbies, but also returning to old activities which in the 
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early stages of their difficulties, had been lost to them, something which participants said was 
encouraged by their neuropsychologist as a way to reengage with their previous life activities. 
My main hobby before the operation … was model engineering … after the operation 
I wasn’t safe near any of the equipment...last year I decided to have another go...and 
I’m finding that yes I can now use it safely so things do progress … (TP2)  
 Being a “functional person” (TP7) and being useful were key factors for participants, 
despite most being unable to work they had begun to find ways that they could contribute, 
and this was key in helping them to move forward. Participants described involvement with 
groups and networks, and even participating in this research, as a way they could contribute 
to a better understanding of pituitary tumours, and this helped them to cope.  
...if I can ever say anything or do anything to help publicise it... they’d [a charity 
organisation] like me to do a blog or article on multi-morbidity so … I’m beginning to 
inform others and help where I can … it helps to get it out of my system a little bit as 
well, just to vocalize it really (TP5) 
 Often, methods of coping began to emerge following participants involvement with 
neuropsychological services. Sometimes this was because neuropsychologists were able to 
provide direct coping strategies and sometimes this was because neuropsychological 
involvement providing a new understanding and a fresh sense of hope and motivation for 
participants.  
Discussion 
This study is the first to examine qualitatively the specific experiences of cognitive 
difficulties and neuropsychological testing in people with a pituitary tumour. As such its 
findings represent a first, exploratory examination of these experiences, and how they impact 
on the wellbeing and life experience of this population. Findings here echo the psychological 
and emotional turbulence associated with having any form of brain tumour (Ownsworth, 
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Chambers, Hawkes, Walker & Shum, 2010; Sterckx et al., 2013; Huang, Wartella, Kreutzer, 
Boraddus & Lyckholm, 2001), but highlight cognitive difficulties as a particularly pervasive 
source of difficulty.  
The findings demonstrated an array of life changing cognitive difficulties participants 
experienced. In keeping with known triggers (Guinan et al., 1998; Peace et al., 1997; Peace et 
al., 1998), participants connected cognitive problems to the tumour, surgical and radiological 
interventions and hormonal dysregulation. Additionally, results here suggest cognitive 
difficulties can vary significantly based on stress levels and psychological wellbeing. 
Participants highlighted this as a flaw in neuropsychological testing, as they are not always 
stressed or in distress when being tested. Alternatively, clinical psychologists and 
neuropsychologists may not be communicating their understanding of deficit variability to 
patients following assessment.  
Shock around diagnosis and arising difficulties is a common experience in the 
diagnostic journey for people with a pituitary tumour (Morris & Jackson, 2007; Simpson et 
al., 2014), results here continue this into the post treatment phase and demonstrate 
participants’ experience of being entirely unprepared for cognitive difficulties. Participants 
felt inadequately informed, and this led to two key issues: shock, distress, and inability to 
cope with difficulties, and a lack of trust and faith in professionals. Given the importance of 
the doctor patient relationship in both wellbeing (Kelley, Kraft-Todd, Schapira, Kossowsky 
& Riess, 2014) and treatment adherence (Moore et al., 2004), maintaining trust needs to be 
more carefully considered. Clear potential for cognitive difficulties in previous research and 
findings here, is at odds with the lack of preparation given to participants, suggesting either a 
lack of knowledge and understanding in professionals or a deliberate withholding of 
information. This raises issues of the ability to give informed consent when unaware of all 
potential consequences.  
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Participants had undergone substantial change throughout their journey, and the 
experience of change was (within these findings) closely linked to their experience of 
cognitive difficulties. Participants’ eventual acceptance of never fully recovering led to a 
process of coping and making the best of their lives as they are. This is in keeping with how 
neuropsychology recovery theory considers the integration of the past and present self as key 
in psychological recovery e.g. The Y-Shaped Model (Wilson, Gracey, Evans & Bateman, 
2009) (as discussed in the literature review section). Findings here therefore highlight the 
value of applying neuropsychology theory and rehabilitation to recovery work conducted 
with people with a pituitary tumour.  
The type and level of changes described by participants here mirror the types of 
experiences described in the process of Grief. Kubler-Ross (1969) proposed that during loss 
and grief, people will move through five stages: denial, anger, bargaining, depression and 
acceptance. Whilst not considered fully representative of grief experience, this model does 
help to demonstrate the ways people within this study experienced the loss of their past 
cognitive functioning. A full mapping of these concepts can be found in the critical appraisal 
section of this thesis, however, participants here demonstrated all of the above named stages 
of grief during their experiences, but were both transient in their stage of grief and capable of 
expressing multiple forms of grief concurrently. For example participants were both angry 
with professionals and bargained by wondering ‘what if’. Tying together both the grief and 
change processes described above is a theory of transformational grief, whereby those who 
experience significant loss (traditionally bereavement, but here a loss of self) are 
fundamentally a different person following their experience, than they were before. This is 
perhaps even more prominent for those with neurological difficulty, who experience not only 
a psychological change, but a neuroanatomical one as well. By better understanding the 
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fundamental changes and subsequent sense of loss experienced by people with a pituitary 
tumour, services can better support and intervene when necessary.   
Whilst important, cognitive difficulties form only one part of QoL (e.g. Johnson et al., 
2003; Van Der Klaauw et al., 2008; Page et al., 1997; Tooze et al., 2009), but results here 
would suggest a broad impact on other areas of life. The reported focus of professionals on 
physical (particularly hormonal) symptoms does not reflect the spectrum of support and care 
needs described by participants. This dichotomy led to increasing amounts of distress and 
difficulty as participants fought to be believed. This draining experience should also be 
considered as a potential factor in subsequent performance during neuropsychological testing. 
By the time participants reach neuropsychological services, their tolerance, trust in 
professionals and general energy levels may lead to sub-optimal performance on measures of 
functioning, thus leading to some of the negative narratives seen in these results.  
Findings reinforced the value of neuropsychological input (Owen, 2012) and 
supported the idea that the experience can be a positive one (Bennett-Levy et al., 1994; 
Westervelt et al., 2007). Additionally, the perceived utility of neuropsychological testing was 
related to the ability of the patient to use results as leverage for support, and as a defence 
when others questioned their cognitive abilities. Findings also demonstrated 
neuropsychological testing as a support to self-worth, as participants felt validated and 
vindicated when receiving results, even results which were hard to hear. Possibly the 
perceived value of neuropsychological testing may relate to how difficult participants found it 
to access. By having to fight hard for a service, people may over emphasise the importance of 
their contact to justify the fight itself. It may be important that neuropsychological services 
do not inadvertently support the status quo because the people seen are both relieved to be 
seen and positive about their outcome with the service. The discussion of being ‘cut off’ from 
neuropsychological services following assessment and intervention also raises the question of 
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whether current structures for neuropsychological input are adequately meeting needs. The 
variability in functioning and the perceived lack of support generally may suggest a need for 
change in the standard assessment, formulation, intervention, discharge approach.  
$ When examined collectively the results of this study form an interactive network of 
experiences which have a profound effect on the lives of the people described within this 
research. Figure 2 demonstrates the way each final theme interacted and influenced other 
themes (and therefore other parts of participants’ lives). The themes born of direct 
experiences (My brain just is not working, Invisible but debilitating, and I thought I would be 
cured, more understanding, support and hope are needed) fed into the core existential theme 
(Life will never be the same again) which was fundamentally about change and adjustment. 
This adjustment in turn concluded with participants finding ways to progress their lives 
(Learning to cope). Finally the issue of neuropsychological testing (Neuropsychological 
testing is hard but important) served to aid in understanding cognitive function changes, 
acceptance of the finality of cognitive changes and in finding ways to adjust and cope. This 
interactional understanding of the experiences of cognitive function and associated testing 
(specifically how these experiences underpin wider life experience) represents the unique 
contribution this research makes to the understanding of pituitary tumour experience.  
Clinical Implications  
The nature of most pituitary tumours, being both low grade and located away from 
areas of the brain primarily associated with cognitive function (as opposed to hormone 
production) may lead professionals to erroneously assume cognitive difficulties will be 
unlikely. This research has demonstrated the need for support with cognitive difficulties, and 
this will initially need to come from medical professionals involved in care (GPs, specialist 
doctors, specialist nurses) as these will have the earliest and greatest number of interactions 
through diagnosis and treatment. To better understand the needs of this population, it would 
2"28$
EXPERIENCES OF PEOPLE WITH A PITUITARY TUMOUR 
$$
be necessary for services to begin to scrutinise current practices and investigate what type of 
psychological service may be most useful for people with a pituitary tumour. The level of 
cognitive difficulties and their impact demonstrated in this study, may mean 
neuropsychological services should be more closely involved. This may mean ensuring 
services are available, well publicised and well understood (by both professionals and 
patients). This could be done by establishing standard neuropsychological referral pathways 
when people with a pituitary tumour enter medical services. Additionally neuropsychologists 
could become more involved in the wider multi disciplinary work. However, a more basic 
psychological understanding and on going support structure from wider professionals may be 
sufficient for some people with pituitary tumour. By being more attuned to these needs to 
begin, with professionals could better assess the long-term needs of patients.  
The need for greater understanding of cognitive difficulties has been strongly 
presented in this research. All professionals involved need to have basic knowledge regarding 
the potential cognitive consequences, and patients need to be made aware of potential 
difficulties so they can be prepared. Preparation will help to reduce negative psychological 
consequences, reduce future contacts with services and help in the long-term psychological 
and practical adjustment process. It is the responsibility of all professionals to ensure they are 
providing the best care for both physical and mental health; however neuropsychologists may 
be well placed to increase understanding of cognitive problems in other professionals, 
through earlier involvement in care, and through consultation and training. This may 
represent continuing involvement, or short term educational work which would then be 
disseminated more widely as professionals with better psychological knowledge, then go on 
to train others in their own discipline.  
Findings here suggest cognitive problems affect all areas of life, including physical 
and psychological wellbeing. Despite clear national guidance (National Institute for Health 
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and Care Excellence, 2006) indicating psychological wellbeing should be an important 
consideration for all professionals, participants here described a broad lack of such support. 
Future service developments should focus on more integration of psychological wellbeing 
into the QoL as assessed by professionals working with these patients.  
 Neuropsychological services represented an important supportive factor within 
findings but were not perfect. Neuropsychological services may be limited in their ability to 
remain involved with long term care due to funding or other considerations however patients 
need to be aware of the ability to re-engage with services if they experience continuing 
cognitive decline or mental health difficulties. Common service models of discharge 
following intervention may be better replaced by open-ended care packages. This could 
involve the use of patient for life policies, as are seen in endocrine services, or annual review 
policies seen in services such as epilepsy.  
Neuropsychological services need to be cautious of variability in cognitive problems 
experienced by each person, particularly based on stress levels, and formulations and 
reporting mechanisms should clearly note this. Additionally the experience of being reported 
as within normal ranges may not appreciate the way subtle deficits, or moderate deficits in 
previously high functioning people can be hard to detect but can have a profound impact on 
quality of life. Additionally, neuropsychology services should carefully examine their own 
interactions and outcome measures in light of the idea that patients may have had a lengthy 
and difficult battle to access their service. Helping patients to be realistic about their 
expectations from neuropsychological services and actively promoting neuropsychology to 
wider professionals (thus streamlining referrals) would be helpful steps.  
Limitations and future research  
 Whilst useful, findings need to be considered alongside potential limitations. The 
findings presented here represent only the shared experiences of a small group of people who 
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were all Caucasian and from England (despite wider recruitment). While findings may 
resonate with anyone with a pituitary tumour, they should not be interpreted as representative 
of everyone’s experience. It is also possible this study only captured the experiences of 
people with negative experiences of care and wellbeing, with those who had experienced 
negative interactions with health care professionals potentially most inclined to volunteer. 
The lack of contribution from family and carers may also represent a significant missing 
piece of information.  
 The range of time since diagnosis and treatment was varied, making it possible the 
experiences described by some participants do not accurately represent the most up to date 
treatment and management protocols.  
 This research and its findings provide valuable information to the pituitary tumour 
knowledge base, however there remains a general paucity of research. More quantitative and 
qualitative research is needed to establish a clear knowledge base. In particular, the 
experience of neuropsychological involvement in brain tumour care would benefit from more 
extensive evaluation. The evaluation of cognitive problems as a result of pituitary tumour and 
treatment will need continuing study, particularly if claims regarding near normal QoL with 
current treatment protocols (Capatina et al., 2013) are to be accepted. There would be value 
in research which evaluates current practice, and knowledge and understanding, of 
professionals involved in pituitary tumour care regarding cognitive difficulties. The 
experience expressed by participants here is not a positive one in this regard, and further 
research could establish either the reasons for this, or if this is not representative of wider 
experience. 
Conclusion 
 This research has highlighted the important role cognitive difficulties play in the 
experience of pituitary tumour. For those with cognitive difficulties, the activities of daily 
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living, along with psychological and emotional wellbeing can be significantly impaired. The 
need for clear, accurate and honest information from professionals is paramount, and 
neuropsychological services are ideally placed to support patients alongside other 
professionals. Clinical psychology, neuropsychology, medical and wider services need to 
work together to promote a better understanding of the role of cognitive difficulties in 
pituitary tumour experience.  
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Table 1 – Final themes and constituent superordinate themes 
Participant / 
Theme 
My brain just is 
not working 
Invisible but 
debilitating 
Neuropsychological 
testing is hard but 
important 
I thought I 
would be cured, 
more 
understanding 
and support are 
needed 
 
Learning to 
cope  
Life will never 
be the same 
TP1 
Direct cognitive 
impact 
 
Invisible 
condition 
 
Cognitive 
problems affect 
all areas of life 
 
Neuropsychological 
tests are important 
but potentially 
damaging 
 
 
Searching for 
understanding 
 
No support 
 
 
 
 
 
Coping 
 
Grief for past, 
fear for future 
 
TP2 
Feeling useless 
 
The direct cognitive 
impact 
It affects 
everything but I 
hide it 
Testing is hard but 
gives hope 
 
Medics need to 
understand 
cognitive 
problems better 
 
 
Finding ways to 
cope 
 
Life will never 
be the same 
 
TP3 
Self defeating cycle 
of stress and 
cognitive problems 
 
Cognition and 
mood 
 
Debilitating in all 
areas of life 
 
 
Searching for 
answers and 
belief 
 
Lack of support 
 
 
 
 
Unable to cope 
 
Life will never 
be normal again 
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TP4 
The cognitive 
impact 
 
Mood swings 
 
Everything just 
stops 
It changes you 
and your life 
 
Neuropsychological 
results can be hard 
to hear but are 
important 
 
Cognitive 
problems were a 
surprise 
 
Lack of support 
 
  
TP5 
My brain just 
doesn’t work 
 
Cognitive problems 
The invisible 
condition 
 
Neuropsychological 
testing gives proof 
but isn’t perfect 
 
Neuropsychology 
can be hard to 
access and results 
are not always used 
well 
I thought I would 
be cured 
 
Doctors are not 
prepared for 
cognitive 
problems 
 
Relationship with 
professionals 
matters 
 
More awareness 
is needed 
 
Learning to cope 
 
My life has 
permanently 
changed 
 
TP6 Direct cognitive impact 
I must not let 
others see  
Need for better 
understanding of 
cognitive 
problems 
 
Need for support 
 
Finding coping 
strategies 
 
Striving to get 
back to normal 
 
Loss of past, loss 
of future 
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TP7 
My brain just isn’t 
working 
 
The cognitive 
impact 
 
 Testing is draining but worth it 
They won’t listen 
 
The fight to 
prove difficulties 
 
Not enough 
support 
 
Recovery 
Resignation 
 
The old me 
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Figure 1 – Recruitment Process  
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Figure 2 – Thematic map of final themes and interactions 
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Appendix 2-A – Extended list of physical and psychological difficulties associated 
with varieties of pituitary tumour.  
 
This list was drawn from the Pituitary Foundation website: 
http://www.pituitary.org.uk/information/pituitary-conditions/ 
Physical Psychological / Cognitive 
• Appetite and weight variations 
• behaviourial changes, depression and mood 
swings, occasionally psychological problems 
can be severe 
• Carpal Tunnel Syndrome  
• Changes in blood cholesterol concentrations  
• Coarsening of facial features 
• Constipation 
• Decrease in bone density, increase in rate of 
fracture in middle age and beyond 
• Decrease in lean body muscle 
• Decrease in sex drive 
• Decrease in strength and stamina, reduction 
in exercise capacity 
• Diabetes mellitus 
• Diabetes Insipidus 
• Discharge from breasts   
• Disturbed sleep patterns 
• Anxiety  
• Depression 
• Behavioural changes 
• Introversion 
•  Inability to concentrate 
• Feelings of social 
isolation 
• Memory problems 
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• Dry skin 
• Enlarged hands and feet 
• Excessive sweating and oily skin 
• Tiredness 
• Decreased energy 
• Headaches 
• Impotence  
• Blood pressure problems 
• Increase in hair growth on the face and body  
• Sensitivity to cold or heat 
• Loss of normal menstrual function 
• Pale appearance 
• Reduced body hair 
• Fertility problems 
• Sleep apnoea 
• Slow growth 
• Tendency to bruise easily 
• Susceptibility to infections 
• Vision disturbance 
• Weight gain 
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Appendix 2-B – Example of annotated transcript with emergent themes  
Research Question:  Participant: TP5 
Annotations: 
Descriptive 
Linguistic 
Conceptual 
Transcript Emerging Themes 
 
 
 
 
Co-morbid health problems  
 
Fatigue – mental and physical  
Short term memory loss  
Lots of life changes all at once  
 
 
Brain blanking  
Confusion  
Getting irritable as a result of cog 
problems  
Recognition of the importance of 
surgery – and yet?  
 
 
Invisible condition  
 
Have to persuade people to understand 
What I say vs blood tests  
Need to have faith that people believe 
you  
 
So can you tell me about any cognitive difficulties you’ve experienced from your 
tumour or from the treatment? 
 
Yeah, I’ve got several, I mean I come under the category of multi morbidity now 
because there’s so many different symptoms that have occurred since my surgery 
which was in 2005. Chronic fatigue, both mental and physical, instant memory loss so I 
don’t have too much trouble with long term memory but you know literally something 
I’ve just done I won’t remember that I’ve done it ten seconds later. I’ve lost all my 
afternoons for life because I have to sleep every afternoon, I go off to sleep, it’s not a 
conscious decision, inability to cope with more than a couple of functions at a time, I 
mean lots of these things are so related that it’s almost describing the same thing in 
more than one way but uh brain blanking when over loaded which happens very easily, 
confusion, resultant occasional irritability and desperation, depression, bad dreams and 
really word finding difficulties, it’s all kind of, it’s all linked and it was very much 
after the tumour was removed which was a success because it saved my sight, I’d have 
apparently gone blind had I not had the operation and I think because the tumour had 
done such damage to the pituitary gland he virtually had to remove all of the pituitary 
gland as well, the surgeon who was a brilliant surgeon I will say but they can never tell 
what side effect there’ll been and of course I mean I might be jumping head here 
because this might be for another question but once again because it’s invisible it take 
so much more persuasion to try and get people to understand and you have to, you 
literally have to just then put your faith in the person that they are going to believe you 
because all they need to do is say that’s rubbish you’re blood tests are okay and 
immediately it sounds like you’re making it up so but I was aware of it and I was aware 
of it as a consequence of the surgery so I’m not saying that the surgery in any way, the 
surgery was culpable or anything like that but it was just one of those things that 
 
 
 
 
 
Lots of life changes  
 
Memory  
 
 
 
Brain blanking  
 
 
 
 
 
Invisible condition  
 
 
 
 
 
 
I have to persuade people I 
am struggling 
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Sense of loneliness in words / tone 
No connection between people with 
similar pituitary conditions  
 
 
Fatigue is the biggest problems and 
affects all others  
 
Sleep does not refresh  
 
Disorientated  
 
 
 
 
 
 
 
Early belief that difficulties following 
surgery were short term  
Naturally – use suggests basic 
expectation of full recovery  
 
 
Slow realisation of permanent cog 
damage  
 
Difficult relationship with doctors 
Rude doctors 
Doctors dismissive of reported 
difficulties  
 
happened and I believe that there are others out there that have had similar but 
unfortunately I never get to meet them because they’re normally scattered around the 
country somewhere and you know there’s various phone lines and things like that 
where you can talk to them but I never as yet met anyone face to face with the same 
problems so because it’s invisible I find it very very hard to have to explain to people 
what’s going on. The fatigue is probably the biggest of all the cognitive dysfunctions I 
think that’s pretty mighty, the sleep I have to have in the afternoon isn’t the same as the 
kind of sleep you’d have at night because it doesn’t refresh at all it’s something that 
just comes upon me and I wake up and I feel extremely, it’s almost like a very bad 
hangover to be quite honest, very disorientating. 
 
So you mentioned in there sort of your experience with surgeons and doctors, talking to 
them about your cognitive problems 
 
With various doctors? 
 
Yeah can you talk me through it?  
 
Yeah it was a situation that when was in the, when I was going through the first few 
weeks after surgery naturally I thought any kind of difficulty I was having functioning 
was just the recovery process and eventually once during as the weeks went by and the 
months went by it became clear both to me and my wife and my family in general that 
it was a permanent situation so of course then you just rely so much on the 
understanding and trust of your doctors and the really that the main contact, the person 
that I was due to see at that time who had the most say over what was going on and 
dealt with the blood tests and results of the blood tests what have you was my 
endocrinologist at the time and he ended up being in the end he was very very rude, 
very very dismissive, my wife witnessed that as well, it would be very much, as this 
was the first, my first back up, the first endocrinologist that I had, the first doctor that I 
would discuss my symptoms with post surgery it was very very damaging to me 
because at that time I hadn’t had anyone else say to me hang on TP5 he’s wrong no 
there is more to what you’re saying so everything that he said seemed to kind of belittle 
 
 
 
 
 
 
 
Fatigue  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I thought I would be cured  
 
 
 
 
I slowly realised the 
cognitive damage was 
permanent  
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Difficult doctors damaged trust with 
professionals  
Belittle what is reported by patient  
 
‘cured’ opinion from doctors  
 
 
Doctors not seeing symptoms as 
problems e.g. fatigue  
Doctors don’t acknowledge that 
difficulties have come from surgery  
 
 
Doctors taking information and 
differences for granted and assuming 
patients know this?  
 
Falling out with doctors  
‘Ad nauseam’ – insulting  
 
Doctor becoming defensive when 
patient is upset  
 
Relationship break down  
Some people are determined not to 
listen  
what I was reporting I ended up going away sometimes even doubting myself thinking 
well am I exaggerating here but it was very much a case of your bloods are fine so 
what do you mean, you’re cured you should be okay, oh yeah but I’ve got such and 
such and there were initially he just look like he wasn’t understanding me and 
eventually he became quite insulting about it basically and I said I have to sleep every 
afternoon, well just chill out then he said sometimes as if it’s all very easy, sometimes 
he would have the sheer disbelief that anything that I said was to do with the surgery, 
one day, strangely enough this same person, as I said I’m not mentioning any names at 
this stage, had a moment where he had, he obviously put on a sensible cap for five 
minutes because he suddenly said to me one day you do realize that, he said oh are you 
religious and I said not especially and he said well it must be remembered that 
replacement hormones that we give you are not the same as God gave you, in other 
words you will not be able to function as well with these as you would do with the 
normal hormones and that was probably the one time where he seemed to slip into 
some kind of empathy with me but it got worse and worse and worse to the extent 
where we fell out and he was quite insulting saying things like I’ve gone through this 
with you ad nauseam and I didn’t hear that, my wife picked that up and I eventually 
said to him have you any idea how difficult it is for me to sit here and have to explain 
all of this and not be believed and his response was have you any idea what it feels like 
to have to sit here and listen to this and by that time naturally any relationship if you 
can call it that had broken down because if someone’s determined not to listen to you 
they’re determined not to listen to you I don’t think they’re ever going to, if they are 
that cussed I don’t think they’re ever going to have a moment where they suddenly 
think oh okay I’ll believe you so it was a lost cause so that was my first experience.  
 
 
 
Doctors think I am cured 
but I’m not  
 
 
 
The doctors will not 
believe me  
 
 
 
 
 
 
 
 
 
 
Doctors becoming 
defensive  
 
 
Relationship breakdown 
with professionals  
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Critical Appraisal 
 This critical appraisal of my research will begin by outlining and reflecting on my 
motivations for this project and some of the issues which arose as I completed the research. I 
will then give a reflective discussion of the results, strengths, limitations and potential future 
projects to arise from this research1.  
Development of the Research 
 Knowing I had an interest in neuropsychology I explored a number of ideas relating to 
brain tumour, brain surgery, brain injury and degenerative conditions. These were the areas I 
had most experience in via clinical practice, and those which interested me most. My early 
ideas were to explore neuropsychological testing experience, as I did not believe there to be 
much research in this area, and having conducted many psychometric tests I was aware of 
how complex the experience can be. I approached my field supervisor, whose specialism in 
brain tumour and pituitary tumour led to discussions of this population and my own 
experience in this area. In practice we had both noted a difference between the expectations 
of cognitive problems in pituitary tumour and other types of tumour, and also the significant 
cognitive problems that people with a pituitary tumour could present with. I had also 
conducted neuropsychological testing with people with a pituitary tumour and had noted how 
difficult this process can be, due to factors such as fatigue and stress tolerance. I decided that 
joining the issue of cognitive difficulties with that of neuropsychological testing would be 
potentially beneficial, and proceeded to explore relevant literature. I also noted that much of 
the focus in literature was on physical health (e.g. van der Klaauw et al., 2008 ) and even 
those studies exploring cognitive difficulties (e.g. Tooze, Gittoes, Jones & Toogood, 2009) 
were more concerned with the statistics and locating cause (surgery, radiotherapy or neither), 
rather than psychological wellbeing and real life impact. Having completed this research I 
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ $$$$$$$$$$$$$$$$$$$$
1$I have referred within this paper to the practice of neuropsychologists, but this may also refer to clinical 
psychologists who work in neuropsychological and health settings, or even to wider mental health professionals. $
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feel that this early feeling was reflected in the experiences of my participants, who struggled 
as much with a lack of information and understanding as actual cognitive difficulties. As a 
result I felt there was a significant gap in qualitative research which explored the experiences 
of people with a pituitary tumour, and even more so a gap around cognitive difficulties and 
subsequent neuropsychological involvement.  
Selection of a Qualitative Approach 
 Having conducted both quantitative and qualitative studies in the past I felt I had both 
options open to me when deciding how to conduct this research study. My own preference as 
a researcher was towards taking a qualitative approach, as I have found that this is where I 
find the most professional and personal interest. I have found that my interests in research 
mirror my interests in clinical practice, which is to help others to explore their own 
understanding of themselves, and through this for me to understand them. This is closely 
aligned with Interpretative Phenomenological Analysis (IPA) which posits this process as the 
double hermeneutic involvement, where the researcher is making interpretations about the 
interpretations of the participant (Smith, Flowers & Larkin, 2009). I felt that for the issue of 
cognitive difficulty and resulting neuropsychological involvement, my interest lay with 
exploring the potentially subtle and complex experiences of people with a history of pituitary 
tumour. I felt that a qualitative approach was the best way to achieve this aim, and IPA in 
particular seemed to fit with what I wanted to achieve.  
Issues Arising During the Research Process 
 One of the early difficulties in developing this research was establishing a strong 
proposal for why pituitary tumour was justifiably different enough from other tumour types 
or other forms of brain injury, to warrant specific exploration of cognitive problems and 
neuropsychological testing. My academic supervisor expressed reservations about whether 
this could be achieved and challenged me to find explicit ways in which I could justify this. 
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For me, the process of trying to find these justifications highlighted a wider issue. There is an 
increasing amount of pressure for health research itself to be evidence based. In order to 
conduct a study, researchers are encouraged (as I was) to think not just about whether a study 
has been done before, but why past research would suggest a need for it, why now is the right 
time for the research and how any contribution would be both novel and of utility to 
practitioners.  
 Whilst I recognise the above factors as important, I also felt that to some extent they 
restrict research practice, particularly the idea of exploratory research in fields which have 
little prior work. The potential differences in practice between pituitary tumour and other 
tumour types was one such area. My clinical experience (and that of my supervisor) 
suggested that people with a pituitary tumour often do not expect cognitive problems 
(particularly memory, concentration and executive problems) and this can cause difficulty in 
their personal lives and ability to work. There is, however, no prior research examining this 
idea, so finding research based justification for exploring this was difficult. I therefore had to 
rely on the types of research outlined in my introduction to demonstrate the potential for 
cognitive difficulties, the ongoing debate about the cause of cognitive problems and the wider 
qualitative experiences of people with a pituitary tumour. In doing this I was able to justify 
the components of my study (cognitive problems and neuropsychological testing), whilst 
recognising that the foundation of this study was exploratory and that only through some non 
evidence based exploration (e.g. experiences of services) could the current evidence be 
expanded in a meaningful way.  
 Having established the project I wished to pursue, I needed to consider the best way to 
recruit, and felt I wanted to do this as broadly as possible within the scope of my study. I 
explored the various charities and services which are involved with people with a pituitary 
tumour and found a community of people who often actively wanted to tell their story in 
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newsletters and social media groups, but who also seemed to express a sense of isolation and 
disconnection. As I began to recruit, the majority of people who contacted me were those 
who had had a pituitary tumour and were experiencing cognitive difficulties, but who had had 
no involvement with neuropsychological services. These people could not participate in the 
study I designed, but still shed light on an important feature of this study. My participants had 
all received neuropsychological input, and whilst this had often been hard won and fought 
for, it had been a valuable resource. The people contacting me had not received this support, 
most had no understanding of what neuropsychological services were, and a few said they 
had just been unable to access neuropsychology. This situation was complex, as my desire for 
these people to receive neuropsychological support clashed with the ethical restrictions of my 
study and who could participate. Some discussions with my academic supervisor led me to a 
specific approach of giving a brief explanation of neuropsychology to those who asked to 
know more, and providing ways they could explore the availability of these services for 
themselves (online, through GP, through endocrinology).    
 I believe the numbers of people with a pituitary tumour who told me they were 
experiencing cognitive difficulties but had no knowledge of neuropsychological services is 
perhaps mirrored in existing research, where cognitive problems are discussed, but 
neuropsychological input is rare. People with a pituitary tumour may well have cognitive 
difficulties, but support and neuropsychological input is rarely discussed. It is important to 
me here that I recognise this is not the case for everyone; I have certainly seen within my 
clinical practice that some services have excellent practices for the referral of people with 
pituitary tumour and cognitive difficulties. However, positive referral practices have seemed 
to depend on the approach taken by individual medical and nursing professionals, rather than 
any fixed referral pathway. Were I designing a further study, or a study whose results could 
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adjoin those here, I could focus on this issue and explore pituitary tumour services nationally, 
looking for strengths, weaknesses, commonalities and differences in current practice.  
 Another issue with recruitment was a markedly poor response rate to a broad 
recruitment strategy. Whilst I believe firmly that I recruited enough participants to gain 
interesting and useful results using interpretative phenomenological analysis (IPA), my early 
hope had been to recruit around 12 participants. I believe a number of factors could have 
contributed to this problem with recruitment. The first I have already discussed, which is that 
a large number of people with pituitary tumour and cognitive problems have no knowledge of 
neuropsychology and are not referred. Some support for cognitive problems may also be 
being offered by other professionals (including medical and nursing staff and charitable 
organisations) outside neuropsychology, particularly when problems are relatively minor. 
Next I would want to consider whether the energy and motivation levels of people with a 
pituitary tumour led them to consider participation as too difficult. With hindsight I could 
perhaps have given more reassurance of my ability to tailor the process to participants’ needs. 
I also consider whether for some, their trust in professionals has been so damaged that they 
had no desire to have further interaction with a health care professional such as myself. Lastly 
I am aware that my use of only one National Health Service (NHS) site could have limited 
my participant pool. I did make contact with a number of services, but due to practical 
constraints, time constraints and being unable to find staff willing to support the project, I 
was unable to recruit further in the NHS. Two sites did express interest, but raised concern 
that they were unaware of participants suitable to my recruitment, which further highlights a 
lack of people coming through some neuropsychological services with pituitary tumour.   
 For those who did participate there were a number of ethical considerations which are 
outlined in the ethics section of this thesis, beyond these there were issues which arose as the 
research was conducted. The difficult ongoing relationships that some participants described 
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with professionals required me to consider my role. I had to decide between listening and 
recording only, or helping participants, after the interview, to explore options going forward. 
Following early interviews, and after discussions with my supervisors, I decided that my 
primary role was to listen to participants and help them explore these difficulties for 
themselves, within the context of my research. However, I also ensured that I was able to 
give participants general information about services that they could talk to (such as patient 
liaison services) should they express a wish to do so during the interview or afterwards.  
 There were some practical issues such as the use of medication that raised concerns 
during the interviews. For example one participant was unsure about potential contraindicated 
medications that they had recently started. They stated that they were unsure about this and 
were waiting for the next appointment with their doctor to discuss it, but continuing to take 
their medication. Again after discussion with my supervisor, I contacted the participant to 
encourage them to contact their doctor or GP to discuss the issue. This type of issue meant 
taking an individual approach to participants and being able to respond in a dynamic way to 
issues that may present.     
 The energy levels and stress tolerance of participants was an ongoing consideration 
for me. I needed to be aware of the obvious and subtle signs of fatigue and distress 
throughout my interviews and to respond to these. For example if a participant seemed to be 
tiring, I offered a break, or to return at another time. If a participant was in distress I offered a 
pause in the interview, a break, or further discussion with me about this, depending on what 
they preferred. No participant chose to end an interview early and distress was rare overall, 
but I believe these small adaptations and responses helped participants to contribute in the 
most positive way possible. I also ensured that participants knew they could contact me after 
the interview if there were things they wished to say or had forgotten to say, though no one 
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chose to do this. All participants expressed a desire to see the results of the study, which for 
me demonstrated positive engagement and experience.  
 The last issue I will consider here is the supervisory relationship with my academic 
supervisor throughout this process. This relationship was crucial to my research and for the 
most part was a positive experience, but there were challenges. Given the important nature of 
the supervisory relationship (Eley & Jennings, 2005), we both agreed that reflection on the 
challenges here would be valuable. I have already discussed the emphasis my supervisor had 
placed on forming a project which was distinctive enough to be justifiable. At times I found it 
difficult to match what I was being asked for with how I felt about conducting this research. 
It was only in the later stages of the project, as I became more confident with my work and 
my understanding of the evidence base, that I was able to adequately express how I felt about 
the exploratory nature of this study and how valuable I felt this could be. After we had come 
to this understanding, both our positions became clearer to the other. Reflecting on this, I 
believe this represents the development of independent thought and understanding that can 
and should happen during a project such as this. My early understanding was drawn largely 
from my supervisors, and I based my ideas and work on their advice. As I learnt more and 
became more comfortable with my own understanding, I was able to better form my own 
interpretations and integrate my supervisors’ thoughts with my own, to produce work which I 
can confidently say is my own.  
 The issue of expression and clarity was present throughout the supervisory process. 
An example of this was during the development of the search terms for the literature review. 
In choosing search terms, I initially used terms which would cover only around 90% of brain 
tumours. I did this as I had never seen extensive lists of terms which I thought would be 
required to cover all brain tumour morphologies. When I discussed this with my supervisor 
he expressed that he felt I was not being honest, and that my more limited list was the result 
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of trying to reduce the amount of work I needed to do. This conversation left us both 
frustrated and unfortunately happened just before a holiday period, making further discussion 
difficult. I felt hurt by the accusation of being dishonest, and my supervisor believed that I 
was not making appropriate effort. I do not believe that during this conversation either of us 
expressed our point of view particularly well, though I cannot speak directly for my 
supervisor. In our next meeting we both felt the need to discuss this issue further, and were 
able to honestly and clearly discuss our feelings and come to a better understanding. I was 
able to understand my own position better, to reflect carefully on why my supervisor felt as 
they did and to consider how I would act on this going forward. For me the biggest 
development from this was a determination to prove myself capable, and to ensure that my 
project was as good as I could make it, both for myself and to value the contributions of my 
participants. This is not to say that I did not want to produce a good project before this, only 
that I was able to recognise how best to achieve and demonstrate this more widely.  
Reflection on Results and Implications 
The research study has provided an exploration into the experiences of people with a pituitary 
tumour who experience cognitive difficulties and subsequently interact with 
neuropsychological services. Participants here were each at different stages of the change and 
adjustment process following the exposure of cognitive difficulties as a result of pituitary 
tumour and treatment. As discussed within the research paper, participants experiences can be 
likened to a grief reaction and the stages of change and adjustment can be applied to the 
stages of grief model presented by Kubler-Ross (1969).  
 The reason for examining these results in comparison to a model of grief is to 
highlight the profound sense of loss that participants expressed throughout their interviews. 
People who have lost cognitive function have not just lost practical skills, but their known 
way of life. For participants here this meant changes in their family and social lives, changes 
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to their routines and lifestyle, a loss of their ability to work, a loss of independence and 
importantly a change in and sometimes loss of their sense of self. All of these changes and 
loss could be linked back to their loss of cognitive function. 
 Modern criticism has focussed on the over-simplification presented in this model and 
on the linear, non individual progression of grief presented (Copp, 1998; Corr, 1993). 
Certainly in this study the grieving process for loss of cognitive function (and thus known 
lifestyle) was far from linear, and involved both progression and regression between stages 
and the straddling of multiple stages at once. Despite this, I can see parallels to each of these 
stages in the experiences of participants in this study, which I have outlined in Box 1.  
Box 1 - Participant grief stages based on Kubler-Ross (1969). 
 Denial - When participants learnt of their cognitive difficulties there was a continuing 
sense that difficulties were transient and abilities would recover. This belief was often drawn 
from the lack of discussion of cognitive function during early diagnosis and treatment and the 
lack of concern from professionals. Eventually the continuing presence of difficulties began 
to suggest permanence and precipitated a shift in perspective: “as the weeks went by and the 
months went by it became clear ...that it was a permanent situation so of course then you just 
rely so much on the understanding and trust of your doctors” (TP5) 
 Anger – Participants here expressed anger at healthcare professionals for failing to 
inform them of potential cognitive problems, and for not taking them seriously when they 
discussed cognitive difficulties  
“I recounted my problems to him [consultant] and he would just come back and I 
have to say the tones of the letters…it feels a bit like somebody slapped you across 
the face because they do this thing which is ‘TP7 reports, however everything is 
fine’…you sort of lose the respect...it’s as though you’re constantly being put down” 
(TP7) 
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 Additionally there was notable anger around the difficulty in accessing support and 
services such as neuropsychology.  
 Bargaining – This is best characterised by participants’ use of the speculative ‘if 
only’ approach. Participants discussed how, if they had been informed of potential cognitive 
problems, or had known more about risks, or had been able to access support sooner, things 
would have turned out differently or at least they would have felt better about how things are 
 “...there definitely does need to be some sort of support for people that come out of 
 the operation...[it] needs to be sorted out like asap...because it was horrible... I thought 
 I was dying... there just needs to be more understanding” (TP4) 
 Depression – Mood difficulties were highly prevalent here. Low mood permeated a 
variety of experiences, from pre diagnosis to final acceptance. Low mood was changeable, 
and subject to the influence of external and internal factors such as social situation, support, 
or current thinking processes: “[reading a letter] his sleep is poor and he is frequently tearful 
and agreed that he is depressed at the moment$which is another factor ...to these collapses” 
(TP3) 
 Acceptance – As discussed in both the ‘Life will never be the same’ the ‘Learning to 
cope’ themes, acceptance was an eventual end point for a number of participants. Acceptance 
was sometimes a positive way to move forward, and sometimes a cause of further low mood 
as the permanency of their situation became apparent: “I tell the doctors look I’ve got it, lets 
get on with it” (TP6) 
 
 The emotion that participants attributed to their experience of cognitive difficulties is 
in stark contrast to the way they described the balance of their care. Much like my 
exploration of literature, participants experienced a much greater focus from professionals 
towards physical health over psychological and cognitive wellbeing. The description by 
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participants of needing to convince some professionals that they were experiencing cognitive 
difficulties could be concerning, and would warrant further exploration within pituitary 
services. This could be achieved through audits of current practice and knowledge, through 
further research into the relationships between pituitary patients and professionals and 
through the sharing of existing positive practice amongst professionals. As noted in the 
discussion section of the research report, it is possible that a significant number of people 
with a history of pituitary tumour either choose not to pursue support, or are unable to, 
because of barriers currently in place.  
 The relationship between patients and the professionals involved in their care is 
important in factors such as wellbeing (Kelley, Kraft-Todd, Schapira, Kossowsky & Riess, 2014) 
and treatment adherence (Moore et al., 2004). Early relationships with professionals will form 
the foundation of trust in healthcare services, which will impact on future interactions. This 
could be considered in the context of attachment theory, which would highlight the 
importance of early positive interactions in building strong relationships and how these 
interactions will affect future relationship building (Bowlby, 1973; Silver, 2013).  For 
neuropsychologists the consideration is often of the importance of the therapeutic relationship 
(Horvath & Symonds, 1991; Lambert & Barley, 2001; Martin, Garske & Davis, 2000), but 
the ability to establish a positive therapeutic relationship may be coloured by earlier 
interactions with other professionals. In considering this it may be beneficial to future 
therapeutic relationships for neuropsychologists to be involved in care during the early stages 
of diagnosis (providing the client wishes this).  
 The consistent discussion by participants was that positive relationships with 
professionals were damaged by a lack of information (and thus preparedness) regarding 
cognitive difficulties. This poses a broader issue regarding informed consent as part of the 
treatment process. Informed consent regarding care is a fundamental right of anyone 
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receiving treatment in UK health services (Department of Health, 2013). If people with a 
pituitary tumour are not made aware of all of the possible consequences to their diagnosis and 
treatment, it could be argued that they are not being given enough information to make fully 
informed decisions. By increasing access to this information through the methods described 
in the research paper, clinicians can be more fully assured of their clients’ comprehensive 
understanding when making decisions. 
  Lack of information provision is an issue which, as already discussed, needs further 
exploration. Without the firsthand accounts of professionals it would be difficult to speculate 
as to why information regarding cognitive difficulties was not presented to the participants of 
this study. Additionally, without further information, it would be inappropriate to assume that 
the experiences of participants here is representative of wider experience.  
Reflections on Limitations and Future Research 
 The issue of diversity in recruitment presented in the research paper poses questions 
about why only a demographic of Caucasian, England based candidates who all described 
previous professional occupations was recruited. Given the small numbers involved this 
could be attributed to chance. However I would also suggest the possibility that at least some 
participants here were those with the knowledge, experience and confidence to have sought 
out neuropsychological assessment. Additionally, as mentioned in the research paper, this 
sample may have constituted those people more likely to have confidence in presenting and 
discussing their negative experiences with professionals.  
 One of the early plans for this study was to recruit those whose experience of 
neuropsychological testing had been within one year of their recruitment. During discussions 
with supervisors and potential recruitment sites it became clear that the potential participant 
pool would not support this, and that this restriction would need to be removed. 
Unfortunately this meant that it became more difficult to use results from this study to 
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compare directly to the current practices and protocols of pituitary services. However, most 
participants had fairly recent experience of interacting with a variety of professionals 
regarding their difficulties, and their discussions regarding cognitive difficulties remained 
problematic. The results of this study should also provide a context for the discussion of 
current treatment protocols and quality of life (Capatina et al., 2013). Whilst recent treatment 
developments may offer increased quality of life and fewer potential cognitive difficulties, it 
should be remembered that participants here were told the same thing about hormone 
replacement and were invariably disappointed. Realistic and strongly evidence based 
information should form the foundation of information provided to people with a pituitary 
tumour.  
Conclusion 
 Through this critical appraisal I have hoped to present my reflections on a variety of 
the issues which are pertinent to this research. I have aimed to demonstrate that whilst this 
research project is not without flaws, the information presented in the results and discussion 
still represent a novel and useful set of information which can help to expand current 
understanding of the experience of people with a pituitary tumour. Conducting this research, 
particularly being given access to participants’ stories, has been a privilege for me, and my 
biggest aim is to ensure that the time, effort and contributions of all involved are given the 
best chance to make a difference to the lives of people with pituitary tumours.  
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A12. What is the scientific justification for the research? Please put this in language comprehensible to a lay  person. 
 
Around 8-10% of tumours in the UK are located on the pituitary gland within the brain. Almost all are benign (non- 
cancerous) adenomas and post-mortem examination has revealed that as many as one in four people may have a 
pituitary adenoma and be unaware of it. Tumours on the pituitary gland are split into two main types: functioning and 
non-functioning. The former releases excess endocrine hormones such as prolactin, adrenocorticotropic hormone 
and growth hormone into the blood stream, where the latter does not produce hormones, but can affect the pituitary 
gland and adjacent brain  areas. 
 
The symptoms for both functioning and non-functioning pituitary tumour can range from mild to severe and impact on 
the physical, cognitive and emotional wellbeing of patients. Specific cognitive faculties such as memory, executive 
function as well as mood and    personality are commonly affected in pituitary tumour   patients. 
 
In addition to direct side effects of the tumour, surgical intervention on the pituitary gland can result in permanent 
damage to the gland and create a range of side effects including cognitive deficits and hormone   deficiency. 
Radiotherapy as a common treatment for pituitary adenoma may also negatively impact cognitive function and quality of 
life   though the evidence for this is less clear when compared to surgery  alone. 
 
The role of clinical neuropsychological services in patients with pituitary tumour includes the assessment and    
monitoring of cognitive function and providing psychological and rehabilitative support. The main aims of cognitive 
testing are to provide a functional assessment of cognitive abilities and to aid in the design of rehabilitative programs. 
There is little research surrounding the experience of neuropsychological testing for patients, particularly in the field of 
brain tumour. Research in the wider spectrum of brain disorder shows that the experience of neuropsychological 
testing can be influenced by factors such as expectations and preparation, perceived relevance, length of assessment 
and differences in practice between neuropsychologists. The most common reasons for patient dissatisfaction with 
testing are a lack of helpfulness in understanding and managing the brain tumour and a lack of help in reducing 
associated stress. In traumatic brain injury the experience of neuropsychological testing can provoke feelings of 
anxiety, confusion, anger and frustration and experience can be mediated by factors such as familiarity with assessor 
and fatigue. Due to the rate of regrowth, the progressive nature of tumours and the potential for surgical and on-going 
medical intervention, neuropsychological testing for pituitary tumour patients is often extensive and repeated, including 
large batteries of recommended tests. Patients with a pituitary tumour have described the diagnostic stage of a 
pituitary tumour as a struggle (sometimes against health professionals) and out of their control. Some of the specific 
features of pituitary tumour, such as hormonal dysregulation and low rate of malignancy make the experience of testing 
in this group potentially distinct from other forms of tumour and other brain disorders. The present study seeks to 
acknowledge and understand the unique nature of testing experiences in pituitary tumour patients. 
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participant information sheet and consent form to potential participants. Potential participants will then be able to 
contact the chief investigator or their supervisors in order to express their interest in participating. Following this contact 
the chief investigator will discuss the study with the potential participant and if appropriate, arrange a time for an 
interview. At the interview the chief investigator will confirm all the details on the consent form and ensure the  
participant has understood and accepted these.Interviews will then be conducted, please see below the recruitment 
section for details of the process from  here. 
 
- Local Charity Organisations: There are a number of local charities such as Headway, The Brain Tumour Charity and 
Brain Tumour Research which have involvement with service users who may be suitable candidates for participation. 
Discussion with regional coordinators for these charities has suggested that the most appropriate way to recruit these 
service users is to make contact with local branches of the charities when the study is ready to recruit. The chief 
investigator will then be able to provide confirmation of ethical approval and request that local charity staff distribute the 
information sheet and consent form to potential participants. Potential participants will then be able to contact the chief 
investigator or their supervisors in order to express their interest in participating. Following this contact the chief 
investigator will discuss the study with the potential participant and if appropriate, arrange a time for an interview. At the 
interview the chief investigator will confirm all the details on the consent form and ensure the participant has 
understood and accepted these. Interviews will then be conducted, please see below the recruitment section for 
details of the process from here. 
 
- Social Media / Online Recruitment: Recruitment through social media and online recruitment will involve distributing a 
simple message regarding the study on social media such as Twitter and Facebook and also on internet forums who 
may have members who would be possible candidates for participation. For details of the messages to be put out, 
please see the documents attached to this application. Potential participants will then be able to contact the chief 
investigator or their supervisors in order to express their interest in participating. Following this contact the chief 
investigator will discuss the study with the potential participant and if appropriate, arrange a time for an interview. At the 
interview the chief investigator will confirm all the details on the consent form and ensure the participant has 
understood and accepted these.Interviews will then be conducted, please see below the recruitment section for details 
of the process from here. 
 
Interviews: 
 
- In addition to the consent information, participants will be made aware that they can opt to be informed of the study 
results, by either receiving a copy of the study or having a telephone conversation with the chief investigator following 
successful submission of the research. Interviews will last approximately 60 minutes and will follow the topic guide 
(see attached documents). Should participants show any signs of distress during the interviews they will be offered the 
option of a break or to discontinue the interview. After the interview participants will be reminded that should they wish  
to seek support or advice there are people available to discuss any issues with them. 
 
 
Post Interviews: 
 
Following the interviews (which will follow a format as laid out in the documents attached to this application) the audio 
recordings of interviews will be transcribed by the chief investigator. All recordings and transcriptions will be given a 
pseudonym and any identifying data removed. Transcribed data will be analysed using   interpretative 
phenomenological analysis. This analysis will be checked with both the field and academic supervisor during the 
process. The final report will be submitted as partial fulfillment towards the Doctorate in Clinical Psychology at    
Lancaster University. This process involves additional presentation of the study to academic groups and a viva. The 
study may also be published. Following successful completion of the study, participants will be contacted (if they 
requested this). 
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D1. Declaration by Chief Investigator 
 
1. The information in this form is accurate to the best of my knowledge and belief and I take full responsibility for it. 
 
 
2. I undertake to abide by the ethical principles underlying the Declaration of Helsinki and good practice 
guidelines on the proper conduct of research. 
 
3. If the research is approved I undertake to adhere to the study protocol, the terms of the full application as 
approved and any conditions set out by review bodies in giving approval. 
 
4. I undertake to notify review bodies of substantial amendments to the protocol or the terms of the approved 
application, and to seek a favourable opinion from the main REC before implementing the amendment. 
 
5. I undertake to submit annual progress reports setting out the progress of the research, as required by review 
bodies. 
 
6. I am aware of my responsibility to be up to date and comply with the requirements of the law and relevant 
guidelines relating to security and confidentiality of patient or other personal data, including the need to register 
when necessary with the appropriate Data Protection Officer. I understand that I am not permitted to disclose 
identifiable data to third parties unless the disclosure has the consent of the data subject or, in the case of 
patient data in England and Wales, the disclosure is covered by the terms of an approval under Section 251 of 
the NHS Act 2006. 
 
7. I understand that research records/data may be subject to inspection by review bodies for audit purposes if 
required. 
 
8. I understand that any personal data in this application will be held by review bodies and their operational 
managers and that this will be managed according to the principles established in the Data Protection Act 
1998. 
 
9. I understand that the information contained in this application, any supporting documentation and all 
correspondence with review bodies or their operational managers relating to the application: 
 
l Will be held by the REC (where applicable) until at least 3 years after the end of the study; and by NHS 
R&D offices (where the research requires NHS management permission) in accordance with the NHS 
Code of Practice on Records Management. 
l May be disclosed to the operational managers of review bodies, or the appointing authority for the REC 
(where applicable), in order to check that the application has been processed correctly or to investigate 
any complaint. 
l  May be seen by auditors appointed to undertake accreditation of RECs (where applicable). 
l Will be subject to the provisions of the Freedom of Information Acts and may be disclosed in response 
to requests made under the Acts except where statutory exemptions apply. 
l May be sent by email to REC members. 
 
10. I understand that information relating to this research, including the contact details on this application, may be 
held on national research information systems, and that this will be managed according to the principles 
established in the Data Protection Act 1998. 
 
11. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I 
understand that the summary of this study will be published on the website of the National Research Ethics 
Service (NRES), together with the contact point for enquiries named below. Publication will take place no earlier 
than 3 months after issue of the ethics committee’s final opinion or the withdrawal of the application. 
 
Contact point for publication(Not applicable for R&D Forms) 
NRES would like to include a contact point with the published summary of the study for those wishing to seek further 
information. We would be grateful if you would indicate one of the contact points  below. 
Chief Investigator 
Sponsor 
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D2. Declaration by the sponsor's representative 
 
If there is more than one sponsor, this declaration should be signed on behalf of the co−sponsors by a representative 
of the lead sponsor named at A64-1. 
 
I confirm that: 
1. This research proposal has been discussed with the Chief Investigator and agreement in principle to sponsor 
the research is in place. 
 
2. An appropriate process of scientific critique has demonstrated that this research proposal is worthwhile and of 
high scientific quality. 
 
3. Any necessary indemnity or insurance arrangements, as described in question A76, will be in place before 
this research starts. Insurance or indemnity policies will be renewed for the duration of the study where 
necessary. 
 
4. Arrangements will be in place before the study starts for the research team to access resources and support 
to deliver the research as proposed. 
 
5. Arrangements to allocate responsibilities for the management, monitoring and reporting of the research will 
be in place before the research starts. 
 
6. The duties of sponsors set out in the Research Governance Framework for Health and Social Care will be 
undertaken in relation to this research. 
 
7. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I 
understand that the summary of this study will be published on the website of the National Research Ethics 
Service (NRES), together with the contact point for enquiries named in this application. Publication will take 
place no earlier than 3 months after issue of the ethics committee's final opinion or the withdrawal of the 
application. 
 
8. Specifically, for submissions to the Research Ethics Committees (RECs) I declare that any and all clinical 
trials approved by the HRA since 30th September 2013 (as defined on IRAS categories as clinical trials of 
medicines, devices, combination of medicines and devices or other clinical trials) have been registered on a 
publically accessible register in compliance with the HRA registration requirements for the UK, or that any 
deferral granted by the HRA still applies. 
 
 
 
 
 
Signature: ..................................................... 
 
Print Name: 
 
 
 
Post: 
Organisation: 
 
Date: (dd/mm/yyyy) 
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Research Protocol – Lancaster DClinPsy Service Related Project  
 
 
Study Title: 
 
How do people with a pituitary tumour experience cognitive difficulties and 
neuropsychological testing?  
 
 
Student / Researcher: Ben Dawson (Trainee Clinical Psychologist) 
 
Field Supervisor: Dr Gemma Wall (Clinical Neuropsychologist)  
 
Academic Supervisor: Dr Stephen Weatherhead (Clinical Psychologist, Research Lecturer and 
Clinical Tutor) 
 
 
Introduction 
 
Around 8-10% of tumours in the UK are located on the pituitary gland within the brain (Cancer 
research UK, 2014). Almost all are benign (non-cancerous) adenomas and post-mortem 
examination has revealed that as many as one in four people may have a pituitary adenoma 
and be unaware of it (American Cancer Society, 2014). Tumours on the pituitary gland are split 
into two main types: functioning and non-functioning. The former releases excess endocrine 
hormones such as prolactin, adrenocorticotropic hormone and growth hormone into the blood 
stream, where the latter does not produce hormones, but can affect the pituitary gland and 
adjacent brain areas.  
 
The symptoms for both functioning and non-functioning pituitary tumour can range from mild 
to severe and impact on the physical, cognitive and emotional wellbeing of patients. Specific 
cognitive faculties such as memory and executive function (Grattan-Smith, Moms, Shores, 
Batchelor, & Sparks, 1992; Peace et al.,1997) as well as mood (Guinan, Lowy, Stanhope, Lewis, 
& Kopelman, 1998) and  personality(Pereira, Tiemensma, Romijn, & Biermasz, 2012) are 
commonly affected in pituitary tumour patients. 
 
In addition to direct side effects of the tumour, surgical intervention on the pituitary gland can 
result in permanent damage to the gland and create a range of side effects including cognitive 
deficits and hormone deficiency (Taphoorn & Klein, 2004). Radiotherapy as a common 
treatment for pituitary adenoma may also negatively impact cognitive function and quality of 
life (Noad, Narayanan, Howlett, Lincoln & Page, 2004) though the evidence for this is less clear 
when compared to surgery alone (van Beek et al, 2007).  
 
The role of clinical neuropsychological services in patients with pituitary tumour includes the 
assessment and monitoring of cognitive function and providing psychological and rehabilitative 
support. The main aims of cognitive testing are to provide a functional assessment of cognitive 
abilities and to aid in the design of rehabilitative programs (Vakil, 2012).  
 
There is little research surrounding the experience of neuropsychological testing for patients, 
particularly in the field of brain tumour. Research in the wider spectrum of brain disorder 
shows that the experience of neuropsychological testing can be influenced by factors such as 
expectations and preparation, perceived relevance, length of assessment and differences in 
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practice between neuropsychologists (Bennett-Levy, Klein-Boonschate, Batchelor, McCarter & 
Walton, 1994). 
 
The most common reasons for patient dissatisfaction with testing are a lack of helpfulness in 
understanding and managing the brain tumour and a lack of help in reducing associated stress 
(Westervelt, Brown, Tremont, Javorsky & Stern, 2007). In traumatic brain injury the 
experience of neuropsychological testing can provoke feelings of anxiety, confusion, anger and 
frustration and experience can be mediated by factors such as familiarity with assessor and 
fatigue (Owen, 2012). Due to the rate of regrowth, the progressive nature of tumours and the 
potential for surgical and on-going medical intervention, neuropsychological testing for 
pituitary tumour patients is often extensive and repeated, including large batteries of 
recommended tests (Ferguson, Iverson & Schoenberg, 2011).  
 
Patients with a pituitary tumour have described the diagnostic stage of a pituitary tumour as a 
struggle (sometimes against health professionals) and out of their control (Simpson, Heath & 
Wall, 2014). Some of the specific features of pituitary tumour, such as hormonal dysregulation 
and low rate of malignancy make the experience of testing in this group potentially distinct 
from other forms of tumour and other brain disorders. The present study seeks to acknowledge 
and understand the unique nature of testing experiences in pituitary tumour patients.  
 
Research Objectives 
This study will explore the experience of cognitive difficulties and neuropsychological testing 
in patients with a pituitary tumour. These findings are intended to inform future practice when 
performing such assessments, and managing the care of people who have experienced 
cognitive impacts from tumour. 
 
Methodology  
 
Design: This is a qualitative study which will use semi-structured interviews to collect data. 
Interviews will last approximately 60 minutes and will be conducted in the most convenient 
place for the participant. This may include on NHS sites, the participants home or another 
appropriate local venue.  
 
Participants: The study will aim to recruit participants who have experienced extensive 
neuropsychological testing in the last 2 years as a result of a pituitary tumour. Participants will 
be recruited from multiple NHS sites and through charitable organisations.   
 
 
Inclusion Criteria:  
• Must have experienced a pituitary tumour  
• Must have undergone neuropsychological testing  
• Latest completed neuropsychological testing appointment is no more than 
12 months from date of interview  
 
Exclusion Criteria:  
 
• Must not have communication difficulties which would prevent them from 
understanding the information sheet and consent form and from 
participating in complex discussion around their experiences. This will be 
determined in early discussion with possible participants.  
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Recruitment Procedure: Initial recruitment will occur using NHS patients from multiple NHS 
sites. This will be done in liaison with clinicians working with pituitary tumour patients in their 
respective departments. This will involve initial contact being made with relevant clinicians on 
site, followed by formal ethical approval from the local R&D department. Following this 
information sheets (see Appendix 1) will be provided to clinicians. Clinicians will then be able 
to pass these information sheets on to their patients. This will include active patients and 
previously discharged patients being contacted by local clinicians. All local R&D sites will have 
to give formal approval for discharged patients to be contacted Patients will then be able to 
take the study information and make contact with a member of the research team (likely to be 
the chief investigator) should they wish to discuss participation. Contact will also be made with 
local Neuropsychology Special Interest Groups, which bring together regional clinicians who 
work in the neuropsychology field. If interested these clinicians may then become local 
collaborators for the research and the above process will be followed for ethical application 
with R&D departments.  
 
Recruitment will also be conducted via contact with the local offices of brain tumour and 
cancer charities, to provide information about the study that can be passed on to their 
members. Members will then be able to contact the research team should they wish to discuss 
participation.  
 
Recruitment will also be advertised using social media. Where appropriate the chief 
investigator will contact the owner/moderating team (in the case of online forums) and follow 
all existing guidelines for research recruitment on broader social media platforms (e.g. Twitter 
& Facebook). Please see Appendix 3 for a copy of the message which will be used in social 
media recruitment.  
Formal ethical approval will be sought from the NHS Integrated Research Application System 
(IRAS). IRAS are able to give ethical approval for the recruitment of NHS patients and 
community based recruitment.   
 
 
Data Collection Procedure: Once potential participants have made contact, they will be 
offered the opportunity to discuss further participation in the study and what this will involve. 
If those who make contact wish to proceed with participation, the chief investigator will then 
arrange a mutually convenient time and place to conduct interviews. At the beginning of each 
interview the chief investigator will re-discuss the detail of participation and ask the 
participant to sign a consent form (see Appendix 2). The interviews will follow the interview 
schedule available in appendix 4.  
 
Proposed Analysis  
 
The results of this study will be analysed using Interpretative Phenomenological Analysis (IPA). 
IPA has been chosen for a number of reasons. Firstly there is no predetermined hypothesis to 
this study and IPA allows a flexible, exploratory approach to examining a research area (Smith, 
2008 p.55). IPA is also concerned with detail of human experience but recognises the collection 
of this data as an interpretative process (Smith, Flowers & Larkin, 2009 p. 32). The chief 
investigator will be able to use the structure of IPA to reflect on their position when 
interpreting data and discussing the results. This reflective space is important, as the nature 
and experience of brain tumours and brain tumour diagnosis are emotive and will be recognise 
as such in this research.  
 
Sample Size 
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The sample size chosen for this study is 8-12 participants. The typical sample for an IPA study 
range from 3 to 6 participants, with larger sample sizes in PhD level research (Smith, Flowers & 
Larkin, 2009 p. 51). The slightly higher number of participants here reflects the academic level 
of the research and the desire to find meaningful points of shared experience in this 
population.  
  
8-12 is also a realistic number of participants to recruit based on the number of potential 
research sites and recruitment sources. The potential pool of participants at each site varies 
significantly (particularly in the charitable sector) but NHS and charitable sites should reflect 
the tumour demographics, in that around 8-10% of their brain tumour population will have a 
pituitary tumour.  
 
The requirement of IPA to use a homogenous sample will also be met by the study ensuring 
that all participants have the same specific form of brain tumour (pituitary tumour) and thus 
will have experienced similar events as a result.  
 
Procedure  
 
 Recruitment 
 
Initial contact will be made with research sites (R&D departments, local charities and through 
social media). Following the identification of early sites, ethical approval will be sought from 
IRAS. Whilst IRAS is reviewing the project, local R&D departments will receive the same 
documents for review. Once IRAS have granted approval to the study and associated 
documents, final documents will be sent to local R&D departments for final approval. 
Following this documents will be distributed to local sites for them to distribute to potential 
participants. The following breaks down the process for each of the three recruitment arms:  
 
1. NHS Sites: Following confirmation of ethical approval, local clinicians at NHS sites will begin 
to distribute the participant information sheet and consent form to potential participants. 
Potential participants will then be able to contact the chief investigator or their supervisors in 
order to express their interest in participating. Following this contact the chief investigator 
will discuss the study with the potential participant and if appropriate, arrange a time for an 
interview. At the interview the chief investigator will confirm all the details on the consent 
form and ensure the participant has understood and accepted these. Interviews will then be 
conducted, please see below the recruitment section for details of the process from here.  
 
2. Local Charity Organisations: There are a number of local charities such as Headway, The 
Brain Tumour Charity and Brain Tumour Research which have involvement with service users 
who may be suitable candidates for participation. Discussion with regional coordinators for 
these charities has suggested that the most appropriate way to recruit these service users is to 
make contact with local branches of the charities when the study is ready to recruit. The chief 
investigator will then be able to provide confirmation of ethical approval and request that 
local charity staff distribute the information sheet and consent form to potential participants. 
Potential participants will then be able to contact the chief investigator or their supervisors in 
order to express their interest in participating. Following this contact the chief investigator 
will discuss the study with the potential participant and if appropriate, arrange a time for an 
interview. At the interview the chief investigator will confirm all the details on the consent 
form and ensure the participant has understood and accepted these. Interviews will then be 
conducted, please see below the recruitment section for details of the process from here.  
 
3. Social Media / Online Recruitment: Recruitment through social media and online 
recruitment will involve distributing a simple message regarding the study on social media such 
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as Twitter and Facebook and also on internet forums who may have members who would be 
possible candidates for participation. For details of the messages to be put out, please see the 
documents attached to this application. Potential participants will then be able to contact the 
chief investigator or their supervisors in order to express their interest in participating. 
Following this contact the chief investigator will discuss the study with the potential 
participant and if appropriate, arrange a time for an interview. At the interview the chief 
investigator will confirm all the details on the consent form and ensure the participant has 
understood and accepted these. Interviews will then be conducted, please see below the 
recruitment section for details of the process from here. 
 
Interviews 
 
In addition to the consent information, participants will be made aware that they can opt to be 
informed of the study results, by either receiving a copy of the study or having a telephone 
conversation with the chief investigator following successful submission of the research. 
Interviews will last approximately 60 minutes. Should participants show any signs of distress 
during the interviews they will be offered the option of a break or to discontinue the 
interview. After the interview participants will be reminded that should they wish to seek 
support or advice there are people available to discuss any issues with them.  
 
Post Interview 
 
Following the interviews (which will follow a format as laid out in the documents attached to 
this application) the audio recordings of interviews will be transcribed by the chief 
investigator. All recordings and transcriptions will be given a pseudonym and any identifying 
data removed. Transcribed data will be analysed using interpretative phenomenological 
analysis. This analysis will be checked with both the field and academic supervisor during the 
process. The final report will be submitted as partial fulfilment towards the Doctorate in 
Clinical Psychology at Lancaster University. This process involves additional presentation of the 
study to academic groups and a viva. The study may also be published. Following successful 
completion of the study, participants will be contacted (if they requested this).  
 
 
Practical Issues  
 
An appropriate meeting place will need to be found for each interview. This can be done whilst 
interviews are being scheduled. These rooms will need to be quiet enough to interview and be 
at a location where participants feel secure enough to discuss the topic. Some interviews may 
be conducted on NHS sites and this will be discussed with local R&D departments and made 
clear on ethical application forms. Some may be at participants homes or local locations, in 
these cases the chief investigator will follow the lone worker policy set out by Lancaster 
University. In regards to costs, all photocopying and printing of documents will be done at 
Lancaster University and therefore the cost will be covered as part of the DClinPsy course. 
Some minor travel costs (i.e. to participants homes or up to £10 for participants to travel) may 
be claimed as part of the research, Lastly, as detailed above, all data will be sorted on secure 
servers at Lancaster University at the earliest opportunity after interview. This is in 
compliance with data protection policies of the university and local NHS trust.  
 
 
Ethical Issues 
 
There are some potential ethical issues concerning the participants of this study which have 
been considered as part of this protocol. Participants are being asked to discuss and consider 
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experiences which are likely to have been distressing. This has the possibility to cause further 
distress in participants. The study may also be fatiguing for participants and this could cause 
physical and emotional discomfort. Additionally some participants may be active patients in 
the NHS and have concerns about the effect of reporting negative experiences on their future 
treatment. In considering all of these issues it is a clear that a clear and open explanation of 
the study itself is required before participants agree. Participants will need to be monitored 
carefully during the study and given the opportunity to fully debrief afterwards by discussing 
their involvement with myself, their local clinician (where appropriate) or Dr Stephen 
Weatherhead. Participants will also be encouraged to carefully consider their participation and 
reassured about anonymity and support available. Types of available support are discussed on 
the information sheet. Informed consent for the study must be realistic and accurate to the 
potential benefits but also the limitations of the study. Feedback of the study results will also 
be important to help participants see their participation in a meaningful way.   
 
In addition to these participant-based concerns there are some ethical issues for consideration 
in the practice of myself as the researcher. Firstly any discussions which prompt concerns 
about mistreatment of patients will need to be reported to Dr Stephen Weatherhead for 
further consideration. All participants will be aware of this process via the information sheet 
and consent form. There is also a need to protect the anonymity of any staff that may be used 
as examples during discussion. To ensure this, participants will be asked to try to give alias 
names to anyone they may discuss in addition during transcription a further randomly selected 
name will be assigned to anyone mentioned. Interviews may also require me to travel to 
participants homes or local facilities to conduct interviews, in this case I will adhere to the 
Lancaster University Lone Worker Policy (See Appendix 5) to ensure my safety.  
 
 
Timescale 
 
October 2014 – Ethical approval process completed  
October/November 2014 – Interviews conducted  
October / November 2014 – Interviews transcribed  
November / December 2013 – Data analysis  
First Draft complete – December 2014 – January 2015 
Second Draft complete – January 2015 – February 2015 
Final Submission – May 2014.  
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Messages for Public Recruitment 
 
 
Message to be posted on Twitter:  
 
Study looking at experience of people with a pituitary tumour. Please see this website for 
further details: http://tinyurl.com/ohat84e Please RT 
 
 
 
Message to be posted on Facebook:  
 
Hi,  
 
My name is Ben Dawson and I am a Trainee Clinical Psychologist at Lancaster University. I’m 
conducting a research project looking at the experiences of people with a pituitary tumour 
who have experienced difficulties with cognitive function and have been through 
neuropsychological testing (such as intelligence tests and other formal tests).  
 
For further information about participating, please read the details on this website:  
 
 http://tinyurl.com/ohat84e 
 
Thanks,  
 
Ben Dawson.  
 
 
 
Message to be posted to Internet forums:  
 
Hi,  
 
My name is Ben Dawson and I am a Trainee Clinical Psychologist at Lancaster University. I’m 
conducting a research project looking at the experiences of people with a pituitary tumour 
who have experienced difficulties with cogntivie function and have been through 
neuropsychological testing (such as intelligence tests and other formal tests).  
 
For further information about participating, please read the details on this website:  
 
http://tinyurl.com/ohat84e 
 
Thanks,  
 
Ben Dawson.  
 
 
 
 
 
 
 
 
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$4"38$
 
$
 
Message to be posted on charity websites:  
 
Hi,  
 
My name is Ben Dawson and I am a Trainee Clinical Psychologist at Lancaster University. I’m 
conducting a research project looking at the experiences of people with a pituitary tumour 
who have experienced difficulties with cognitive function and have been through 
neuropsychological testing (such as intelligence tests and other formal tests).  
 
Participating would involve meeting with me for an interview of around an hour at a location 
convenient to you.  
 
For further information about participating, please read the details on this website:  
 
http://tinyurl.com/ohat84e 
 
If you prefer you can contact me at b.dawson@lancaster.ac.uk or by post using the expression 
of interest form and I will be happy to email or mail you a copy of the information sheet and 
consent form. By contacting me you are not agreeing to participate and I will not contact you 
again unless you get back in touch to express your interest in participating.  
 
Thanks,  
 
Ben Dawson.  
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Participant Information Sheet          
 
 
How do people with a pituitary tumour experience cognitive difficulties and 
neuropsychological testing?  
 
My name is Ben Dawson and I am conducting this research as a student of the Doctorate in 
Clinical Psychology at Lancaster University.  
 
What is the study about? 
The purpose of this study is to explore the experiences of patients with a pituitary tumour. I 
am particularly interested in cognitive difficulties and neuropsychological testing.  
 
Why have I been approached? 
You have been approached because you may meet the criteria of having a pituitary tumour, 
cognitive difficulties and experience of neuropsychological testing.  
 
Do I have to take part? 
No, it’s completely up to you to decide whether or not you take part but I think your 
participation can be very valuable and help to make changes to services in future.  
 
What will I be asked to do if I take part? 
If you decide you would like to take part, you would be asked to complete an interview of 
around 1 hour where you will be asked questions about your experiences. These interviews can 
be at your home, in a local venue or at your hospital, whatever you prefer. If needed this 
interview can be broken down in to several shorter interviews.  
 
Can I be identified from my data? 
All the information you provide is made anonymous after your interview. The data collected for 
this study will be stored securely and only I will have full access to this data.  
o Audio recordings will be encrypted and password protected on a computer, so no one 
other than me will be able to access them). After they have been transcribed and 
checked the recordings will be destroyed.  
o Your consent form will be stored securely at Lancaster University in a locked cabinet for 
10 years, after which it will be destroyed. Your consent form cannot be linked to your 
data.    
o The typed version of your interview will be made anonymous by removing any 
identifying information, including your name, and will be kept securely in electronic 
format for 10 years. At the end of this period, they will be destroyed. 
o My academic supervisor (Stephen Weatherhead) will have access to anonymous 
transcripts to help me analyse the information and my field supervisor (Gemma Wall) 
will have access to the data once it has been analysed. You will in no way be 
identifiable to either of my supervisors. 
If something you say during the interview makes me think that you or someone else is at 
significant risk of harm, I will have to speak to my research supervisor and possibly other 
services about this. If possible, I will tell you if I have to do this. 
 
What will happen to the results? 
The results will be summarised and reported and may be submitted for publication in an 
academic or professional journal. Anonymous quotations from your interview may be used in 
the reports or publications from the study.  
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Are there any risks? 
You will be asked to talk about times you have experienced neuropsychological testing and 
cognitive difficulties, we realise that this could be upsetting and would aim to support you with 
this. If you experience any distress you can talk to me about this, or any of the contacts at the 
end of this sheet. I will also be able to signpost you to more support if you feel you need it. 
Your hospital care will not be affected in any way.  
 
Are there any benefits to taking part? 
Although you may find participating interesting, there are no immediate benefits in taking 
part. After the research has been completed the information may be used to help develop 
services. If you need to travel to the interview, Lancaster University will pay up to £10 in 
travel expenses. I can give you the form to claim this either before or after your interview.  
 
Can I withdraw from the study?  
You can change your mind about participating at any time before your interview. If you wish to 
withdraw your interview material after your interview, you can request this up to 2 weeks 
after your interview and your data will be destroyed. After this your information will have been 
merged with other data and will not be removable.  
 
Who has reviewed the project? 
This study has been reviewed by an NHS Research and Ethics Committee. This is an ethics body 
that review projects with NHS patients.  
 
Where can I obtain further information about the study if I need it? 
If you have any questions about the study, please contact my project supervisors or me as the 
main researcher: 
 
Ben Dawson 
Trainee Clinical Psychologist 
B.dawson@lancaster.ac.uk 
 
Dr Stephen Weatherhead 
Clinical Tutor  
S.weatherhead@lancaster.ac.uk 
Dr Gemma Wall  
Clinical Neuropsychologist 
Gemma.Wall@srft.nhs.uk 
 
 
I think I want to take part  
If you have read all the information and think you want to take part, please look at the 
Expression of Interest form for details of how to make contact by email or post.  
 
Complaints  
If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researchers, you can contact: 
 
Dr Jane Simpson (Research 
Director)  
Tel: 01524 592858 
Email: 
j.simpson2@lancster.ac.uk  
Division of Clinical Psychology 
Lancaster University  
LA1 4YD 
Professor Roger Pickup (Associate Dean for 
Research)  
Tel: 01524 593746  
Email: r.pickup@lancaster.ac.uk 
Faculty of Health and Medicine  
Lancaster University  
LA1 4YD  
 
Thank you for taking the time to read this information sheet
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Expression of Interest Form 
If you have read the information sheet and think that you might want to get some more 
information or take part in this study, please either contact me on the email address below or 
send this form back to the address below and I will get in touch with you.   
I will contact you to talk more about the study and then I will ask you to confirm that you 
would like to take part. Then we can arrange a convenient time to meet. I can provide you 
with electronic or written copies of the information sheet and consent form at any time and 
these will be available before your interview.  
To contact me directly just email me at: b.dawson@lancaster.ac.uk or send the below slip 
with your details to:  
 
Ben Dawson 
Clinical Psychology Department 
C Floor, Furness Building 
Lancaster University  
Lancaster 
LA1 4YW 
----------------------------------------------------------------------------------------- 
I agree to Ben Dawson calling me on the telephone number below to discuss this study, or 
emailing me on the below email.  
My name is ___________________________________________ 
Signature:___________________________________________  
Date:____________ 
The best telephone number to use is:_______________________________ 
The best email to contact me with is:______________________________ 
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Participant Consent Form 
 
 
Study Title:  How do people with a pituitary tumour experience cognitive difficulties and 
neuropsychological testing?  
 
We are asking if you would be willing take part in a research project aimed at exploring the 
experiences of patients with a pituitary tumour. The study focuses on experiences of cognitive 
difficulties and neuropsychological testing.   
 
Before you consent to participating we ask that you read the participant information sheet and 
mark each box below if you agree.  If you have any questions or queries before signing the 
consent form please contact Ben Dawson, Stephen Weatherhead or Gemma Wall (contact 
details are on the information sheet) 
 
 
1. I confirm that I have read the information sheet and fully 
understand what is expected of me within this study  
2. I confirm that I have had the opportunity to ask any questions 
and to have them answered.  
3. I understand that my interview will be audio recorded and then 
made into an anonymised written transcript. 
4. I understand that audio recordings will be kept until the 
research project has been assessed.  
5. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason.  
6. I understand that I have up to two weeks after my interview to 
ask for my data to be removed from the study.  
7. I understand that the information from my interview will be 
pooled with other participants’ responses, anonymised and may 
be published 
8. I consent to information and quotations from my interview 
being used in reports, conferences and training events.  
9. I understand that any information I give will remain strictly 
confidential and anonymous unless it is thought that there is a 
risk of harm to myself or others, in which case the main 
researcher may need to share this information with their 
research supervisor or other agencies.  
10. I consent to Lancaster University keeping my consent form and 
written transcriptions of the interview for 10 years after the 
study has finished.  
11. I consent to take part in the above study.    
 
Name of Participant:                             Signature:                    Date: 
 
Name of Researcher:                             Signature:                    Date:  
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Interview Schedule 
 
Questions about Cognitive Decline  
 
1. Tell me about any cognitive difficulties you have experienced from your tumour or 
treatment  
 
Prompts: What kind of cognitive difficulties did you experience?  
How did your cognitive difficulties affect you?  
 
 
2. How did you first know you were experiencing cognitive difficulties?  
 
Prompts: What alerted you to possible cognitive difficulties?  
Did anyone around you notice difficulties?  
 
 
3. How did you feel about having cognitive difficulties?  
 
Prompts: Did you ever expect some cognitive difficulties?  
Had anyone talked to you about the possibility of difficulties?  
 
Questions about Neuropsychological Assessment 
 
1. Why were you referred for neuropsychological assessment?  
 
Prompts: How was the assessment arranged?   
How was the reason for the assessment explained to you?  
How did you feel about being referred for assessment?  
 
 
2.  Can you tell me about the assessment you underwent?  
 
Prompts: What was the purpose of the assessment? 
How was the assessment explained to you?  
How did you feel while you were being assessed?  
 
 
3. Tell me about the results of the assessment  
 
Prompts: What were the main findings?  
What were you told about the results? 
How were the results explained to you?  
Were the assessment process and the results useful?  
How did you feel about the results?  
 
 
General Prompts: Can you tell me a bit more about that? What do you mean by ‘X’? How 
did you feel about that?  
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01 December 2014 
Mr Benjamin Dawson 
Trainee Clinical Psychologist 
Lancashire Care NHS Foundation Trust 
Floor C, Furness Building 
Lancaster University 
Lancaster 
LA1 4YG 
 
 
Dear Mr Dawson 
NRES Committee East of England - Norfolk 
The Old Chapel 
Royal Standard Place 
Nottingham 
NG1 6FS 
Telephone:  01158839390 
 
Study title: How do people with a pituitary tumour  experience 
cognitive difficulties and neuropsychological  testing? 
REC reference: 14/EE/1255 
IRAS project ID: 160174 
 
Thank you for your letter of 27th November 2014, responding to the Committee’s request for 
further information on the above research and submitting revised  documentation. 
 
The further information has been considered on behalf of the Committee by the Lead   Reviewer. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this opinion letter.  Should you wish to provide a substitute contact point, require  
further information, or wish to make a request to postpone publication, please contact the  
REC Assistant,  Tad Jones, NRESCommittee.EastofEngland-Norfolk@nhs.net. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised, subject to the conditions specified  below. 
 
 
Conditions of the favourable  opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of the 
study.
4"45$
 
$
Management permission or approval must be obtained from each host organisation prior to the 
start of the study at the site  concerned. 
 
Management permission ("R&D approval") should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance   arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated Research 
Application System or at  http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this   activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host  organisation. 
 
Sponsors are not required to notify the Committee of approvals from host   organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database within 6 weeks of recruitment of the first participant (for 
medical device studies, within the timeline determined by the current registration and publication 
trees). 
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g when submitting an amendment. We will audit the registration details as part of 
the annual progress reporting  process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but 
for non clinical trials this is not currently  mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be   made. 
Guidance on where to register is provided within  IRAS. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as   applicable). 
 
 
Ethical review of research sites 
 
 
NHS sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
"Conditions of the favourable opinion"  below). 
 
Non-NHS sites 
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Approved documents 
 
The final list of documents reviewed and approved by the Committee is as   follows: 
Document Version Date 
Copies of advertisement materials for research participants 
[Messages for Public  Recruitment] 
1 06 November 2014 
Copies of advertisement materials for research participants 
[Messages for Public  Recruitment] 
2 24 November 2014 
IRAS Checklist  XML [Checklist_06112014] $ 06 November 2014 
IRAS Checklist  XML [Checklist_06112014] $ 06 November 2014 
IRAS Checklist  XML [Checklist_26112014] $ 26 November 2014 
Letter from sponsor [Sponsor  Letter] 1 21 October 2014 
Non-validated questionnaire [Qualitative  Interview Schedule] 1 06 November 2014 
Other [Expression of Interest  Form] 1 24 November 2014 
Other [Covering letter for changes following  REC] 1 24 November 2014 
Participant consent form [Participant Consent  Form] 2 24 November 2014 
Participant information sheet (PIS) [Participant Information   Sheet] 2 24 November 2014 
REC Application Form  [REC_Form_06112014] $ 06 November 2014 
REC Application Form  [REC_Form_26112014] $ 26 November 2014 
Research protocol or project proposal [Thesis  Protocol] 4 24 November 2014 
Summary CV for Chief Investigator (CI) [Ben Dawson  CV] 1 16 October 2014 
Summary CV for supervisor (student research) [Academic 
Supervisor CV] 
1 17 October 2014 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
 
After ethical review 
 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion,   including: 
 
• Notifying substantial amendments 
• Adding new sites and investigators 
• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or  procedures. 
 
 
User Feedback 
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The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the application 
procedure. If you wish to make your views known please use the feedback form available on the HRA 
website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/ 
 
HRA Training 
 
We are pleased to welcome researchers and R&D staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/ 
 
 
 
 
With the Committee’s best wishes for the success of this project. Yours 
sincerely 
 
Dr Michael Sheldon Chair 
 
Email:NRESCommittee.EastofEngland-Norfolk@nhs.net 
 
Enclosures: “After ethical review – guidance  for 
researchers” [SL-AR2] 
 
Copy to: Ms Debbie Knight 
Ms Maureen Daniels, Salford Royal NHS Foundation  Trust 
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Applicant name: Ben Dawson 
 Supervisor: Dr Stephen Weatherhead Department: DHR 
 
 
21 October 2014 
 
 
 
 
Dear Ben and Stephen, 
Re: How do people with a pituitary tumour experience cognitive difficulties and 
neuropsychological testing? 
 
The University of Lancaster undertakes to perform the role of sponsor in the matter of 
the work described in the accompanying grant application. The sponsor as we 
understand it assumes responsibility for monitoring and enforcement of research 
governance. As principal investigator you will  confirm  that  the  institution's 
obligations are met by ensuring that, before the research commences and during the 
full term of the grant, all the necessary legal and regulatory requirements in order to 
conduct the research are met, and all the necessary licenses and approvals have been 
obtained. The Institution has in place formal procedures for managing the process for 
obtaining any necessary or appropriate ethical approval for this grant. Full ethical 
approval must be in place before the research commences and should be reviewed at 
all relevant times during the  grant. 
 
Yours sincerely, 
 
 
 
 
 
Fiona Aiken, 
University Secretary, 
Chair, University Research Ethics Committee. 
Cc Sarah Taylor,  Secretary, UREC. 
Research and Enterprise 
Services 
 
Lancaster University 
Bowland Main 
Lancaster Lf,1 4YT 
United Kingdom 
 
Tel: +44 (0) 1524 592002 
Fax: +44 (0)  1524 593229 
Web:  http://www.l ancs.ac.uk 
 
 
 
 
